

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Epitope specificity and protein signaling... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/4-166/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/4-166" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Epitope specificity and protein signaling interactions driving epidemic occurrences of Ebola disease" />
    
            <meta name="og:title" content="F1000Research Article: Epitope specificity and protein signaling interactions driving epidemic occurrences of Ebola disease.">
            <meta name="og:description" content="Read the latest article version by Daniel Achinko, Anton Dormer, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="6991">
            <meta name="article-id" content="6515">
            <meta name="dc.title" content="Epitope specificity and protein signaling interactions driving epidemic occurrences of Ebola disease">
            <meta name="dc.description" content="Ebolavirus has as main hosts, humans and nonhuman primates where its pathogenic effects result to serious hemorrhagic fever with lethal effects. Despite the great advancement in deciphering the clinical course of the virus, specific mechanisms favoring Ebolavirus pathogenicity and transmission, and which genomic structures are most antigenic, are still to be clearly delineated. This study used functional protein phylogenetic analysis, pathway designs and antigenic epitope predictions to respectively; identify viral genomic regions closely related to host proteins, predict protein/genetic interactions favoring viral pathogenesis and identify frequency of MHC class I &amp;amp; II immune related host peptide variants whose transmission intensity value favors disease epidemicity. Viral glycoprotein (VGP) presented the highest genetic variation and though captured on the network with matrix protein (MXP), no direct interaction was observed. The majority of host interacting proteins presented with kinase functions, particularly a protein-signaling role observed in LCK, a Tyrosine-protein kinase with the most dominant interactions and viral related functions implicated in disease shock events. Four VGP and three MXP main antigenic epitopes identified, differentially showed high frequency to two MHC class I types. The same pattern was observed for VGP and MXP antigenic epitopes predicted to MHC class II allele variants, favoring high transmission intensity values within the host population, suggesting their involvement in Ebola epidemic upsurges. Related Ebola species with high transmission values were dominantly non-Zaire Ebolaviruses whose antigenic regions showed several repeats, implicating them in viral antigenic variations. Our analysis show that VGP and MXP are both critical for viral entry and pathogenicity in the host and with their species specific occurrence, their combined role in drug/vaccine design is critical. The identification of several antigenic epitopes in this study will be used in combination for drug/vaccine design and for better understanding related molecular targets in pathogenic pathways favoring Ebola disease burden.">
            <meta name="dc.subject" content="Ebolavirus, pathogenicity, transmission, Major histocompatibility complex (MHC), Immune epitopes, protein interactions">
            <meta name="dc.creator" content="Achinko, Daniel">
            <meta name="dc.creator" content="Dormer, Anton">
            <meta name="dc.date" content="2015/06/24">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.6515.1">
            <meta name="dc.source" content="F1000Research 2015 4:166">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="Ebolavirus ">
            <meta name="prism.keyword" content=" pathogenicity ">
            <meta name="prism.keyword" content=" transmission ">
            <meta name="prism.keyword" content=" Major histocompatibility complex (MHC) ">
            <meta name="prism.keyword" content=" Immune epitopes ">
            <meta name="prism.keyword" content=" protein interactions">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2015/06/24">
            <meta name="prism.volume" content="4">
            <meta name="prism.number" content="166">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.6515.1">
            <meta name="prism.url" content="https://f1000research.com/articles/4-166">
            <meta name="citation_title" content="Epitope specificity and protein signaling interactions driving epidemic occurrences of Ebola disease">
            <meta name="citation_abstract" content="Ebolavirus has as main hosts, humans and nonhuman primates where its pathogenic effects result to serious hemorrhagic fever with lethal effects. Despite the great advancement in deciphering the clinical course of the virus, specific mechanisms favoring Ebolavirus pathogenicity and transmission, and which genomic structures are most antigenic, are still to be clearly delineated. This study used functional protein phylogenetic analysis, pathway designs and antigenic epitope predictions to respectively; identify viral genomic regions closely related to host proteins, predict protein/genetic interactions favoring viral pathogenesis and identify frequency of MHC class I &amp;amp; II immune related host peptide variants whose transmission intensity value favors disease epidemicity. Viral glycoprotein (VGP) presented the highest genetic variation and though captured on the network with matrix protein (MXP), no direct interaction was observed. The majority of host interacting proteins presented with kinase functions, particularly a protein-signaling role observed in LCK, a Tyrosine-protein kinase with the most dominant interactions and viral related functions implicated in disease shock events. Four VGP and three MXP main antigenic epitopes identified, differentially showed high frequency to two MHC class I types. The same pattern was observed for VGP and MXP antigenic epitopes predicted to MHC class II allele variants, favoring high transmission intensity values within the host population, suggesting their involvement in Ebola epidemic upsurges. Related Ebola species with high transmission values were dominantly non-Zaire Ebolaviruses whose antigenic regions showed several repeats, implicating them in viral antigenic variations. Our analysis show that VGP and MXP are both critical for viral entry and pathogenicity in the host and with their species specific occurrence, their combined role in drug/vaccine design is critical. The identification of several antigenic epitopes in this study will be used in combination for drug/vaccine design and for better understanding related molecular targets in pathogenic pathways favoring Ebola disease burden.">
            <meta name="citation_description" content="Ebolavirus has as main hosts, humans and nonhuman primates where its pathogenic effects result to serious hemorrhagic fever with lethal effects. Despite the great advancement in deciphering the clinical course of the virus, specific mechanisms favoring Ebolavirus pathogenicity and transmission, and which genomic structures are most antigenic, are still to be clearly delineated. This study used functional protein phylogenetic analysis, pathway designs and antigenic epitope predictions to respectively; identify viral genomic regions closely related to host proteins, predict protein/genetic interactions favoring viral pathogenesis and identify frequency of MHC class I &amp;amp; II immune related host peptide variants whose transmission intensity value favors disease epidemicity. Viral glycoprotein (VGP) presented the highest genetic variation and though captured on the network with matrix protein (MXP), no direct interaction was observed. The majority of host interacting proteins presented with kinase functions, particularly a protein-signaling role observed in LCK, a Tyrosine-protein kinase with the most dominant interactions and viral related functions implicated in disease shock events. Four VGP and three MXP main antigenic epitopes identified, differentially showed high frequency to two MHC class I types. The same pattern was observed for VGP and MXP antigenic epitopes predicted to MHC class II allele variants, favoring high transmission intensity values within the host population, suggesting their involvement in Ebola epidemic upsurges. Related Ebola species with high transmission values were dominantly non-Zaire Ebolaviruses whose antigenic regions showed several repeats, implicating them in viral antigenic variations. Our analysis show that VGP and MXP are both critical for viral entry and pathogenicity in the host and with their species specific occurrence, their combined role in drug/vaccine design is critical. The identification of several antigenic epitopes in this study will be used in combination for drug/vaccine design and for better understanding related molecular targets in pathogenic pathways favoring Ebola disease burden.">
            <meta name="citation_keywords" content="Ebolavirus, pathogenicity, transmission, Major histocompatibility complex (MHC), Immune epitopes, protein interactions">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Daniel Achinko">
            <meta name="citation_author_institution" content="PepVax, Inc.10411 Motor City Drive, Bethesda, MD, 20817, USA">
            <meta name="citation_author_institution" content="Current affiliation: NCBI/NLM/NIH, Computational Biology Branch, Bethesda, MD, 20894, USA">
            <meta name="citation_author" content="Anton Dormer">
            <meta name="citation_author_institution" content="PepVax, Inc.10411 Motor City Drive, Bethesda, MD, 20817, USA">
            <meta name="citation_publication_date" content="2015/06/24">
            <meta name="citation_volume" content="4">
            <meta name="citation_publication_number" content="166">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.6515.1">
            <meta name="citation_firstpage" content="166">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/4-166/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/4-166.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=6991 /> <input type=hidden id=articleId name=articleId value=6515 /> <input type=hidden id=xmlUrl value="/articles/4-166/v1/xml"/> <input type=hidden id=xmlFileName value="-4-166-v1.xml"> <input type=hidden id=article_uuid value=c3d18c77-b1b0-4471-9048-77a997d4794e /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Epitope specificity and protein signaling interactions driving epidemic occurrences of Ebola disease"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.6515.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.6515.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/4-166"
  },
  "headline": "Epitope specificity and protein signaling interactions driving epidemic occurrences of Ebola disease",
  "datePublished": "2015-06-24T15:13:41",
  "dateModified": "2015-06-24T15:13:41",
  "author": [
    {
      "@type": "Person",
      "name": "Daniel Achinko"
    },    {
      "@type": "Person",
      "name": "Anton Dormer"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Ebolavirus has as main hosts, humans and nonhuman primates where its pathogenic effects result to serious hemorrhagic fever with lethal effects. Despite the great advancement in deciphering the clinical course of the virus, specific mechanisms favoring Ebolavirus pathogenicity and transmission, and which genomic structures are most antigenic, are still to be clearly delineated. This study used functional protein phylogenetic analysis, pathway designs and antigenic epitope predictions to respectively; identify viral genomic regions closely related to host proteins, predict protein/genetic interactions favoring viral pathogenesis and identify frequency of MHC class I &amp;amp; II immune related host peptide variants whose transmission intensity value favors disease epidemicity. Viral glycoprotein (VGP) presented the highest genetic variation and though captured on the network with matrix protein (MXP), no direct interaction was observed. The majority of host interacting proteins presented with kinase functions, particularly a protein-signaling role observed in LCK, a Tyrosine-protein kinase with the most dominant interactions and viral related functions implicated in disease shock events. Four VGP and three MXP main antigenic epitopes identified, differentially showed high frequency to two MHC class I types. The same pattern was observed for VGP and MXP antigenic epitopes predicted to MHC class II allele variants, favoring high transmission intensity values within the host population, suggesting their involvement in Ebola epidemic upsurges. Related Ebola species with high transmission values were dominantly non-Zaire Ebolaviruses whose antigenic regions showed several repeats, implicating them in viral antigenic variations. Our analysis show that VGP and MXP are both critical for viral entry and pathogenicity in the host and with their species specific occurrence, their combined role in drug/vaccine design is critical. The identification of several antigenic epitopes in this study will be used in combination for drug/vaccine design and for better understanding related molecular targets in pathogenic pathways favoring Ebola disease burden."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/4-166",
            "name": "Epitope specificity and protein signaling interactions driving epidemic..."
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Epitope specificity and protein signaling interactions driving epidemic... </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=6991 data-id=6515 data-downloads="" data-views="" data-scholar="10.12688/f1000research.6515.1" data-recommended="" data-doi="10.12688/f1000research.6515.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/4-166/v1/pdf?article_uuid=c3d18c77-b1b0-4471-9048-77a997d4794e" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-6515-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-6515-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-6515-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Achinko D and Dormer A. Epitope specificity and protein signaling interactions driving epidemic occurrences of Ebola disease [version 1; peer review: peer review discontinued]</span>. <i>F1000Research</i> 2015, <b>4</b>:166 (<a class=new-orange href="https://doi.org/10.12688/f1000research.6515.1" target=_blank>https://doi.org/10.12688/f1000research.6515.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-6515-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=6515 id=track-article-signin-6515 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/6515?target=/articles/4-166">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=6991 /> <input name=articleId type=hidden value=6515 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Research Article </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Epitope specificity and protein signaling interactions driving epidemic occurrences of Ebola disease</h1><span class=other-info> [version 1; peer review: peer review discontinued]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class=""><a href="mailto:achdany@yahoo.co.uk" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Daniel Achinko</span></a><a href="https://orcid.org/0000-0001-5502-0939" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0001-5502-0939</div><sup>1,2</sup>,&nbsp;</span><span class="">Anton Dormer<sup>1</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class=""><a href="mailto:achdany@yahoo.co.uk" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Daniel Achinko</span></a><a href="http://orcid.org/0000-0001-5502-0939" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0001-5502-0939</div><sup>1,2</sup>,&nbsp;</span><span class="">Anton Dormer<sup>1</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 24 Jun 2015 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.6515.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> PepVax, Inc.10411 Motor City Drive, Bethesda, MD, 20817, USA<br/> <sup>2</sup> Current affiliation: NCBI/NLM/NIH, Computational Biology Branch, Bethesda, MD, 20894, USA<br/> <p> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <div class="status-row referee-reports-container"> PEER REVIEW DISCONTINUED </div> </div> </div> <div class="f1r-article-desk padding-top"> <div class=article-collection-wrapper> <div class="o-media o-media--sm o-media--center"> <div class=o-media__img> <a href="https://f1000research.com/gateways/disease_outbreaks" title="Open Gateway"><img src="https://f1000researchdata.s3.amazonaws.com/thumbnails/7a40be09-4a0a-485b-9dbb-309abf61cffc_collection.thumbnail"></a> </div> <div class=o-media__body> <p class="u-mt--0 u-mb--0">This article is included in the <a href="https://f1000research.com/gateways/disease_outbreaks">Disease Outbreaks</a> gateway.</p> </div> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Ebolavirus has as main hosts, humans and nonhuman primates where its pathogenic effects result to serious hemorrhagic fever with lethal effects. Despite the great advancement in deciphering the clinical course of the virus, specific mechanisms favoring Ebolavirus pathogenicity and transmission, and which genomic structures are most antigenic, are still to be clearly delineated. This study used functional protein phylogenetic analysis, pathway designs and antigenic epitope predictions to respectively; identify viral genomic regions closely related to host proteins, predict protein/genetic interactions favoring viral pathogenesis and identify frequency of MHC class I &amp; II immune related host peptide variants whose transmission intensity value favors disease epidemicity. Viral glycoprotein (VGP) presented the highest genetic variation and though captured on the network with matrix protein (MXP), no direct interaction was observed. The majority of host interacting proteins presented with kinase functions, particularly a protein-signaling role observed in LCK, a Tyrosine-protein kinase with the most dominant interactions and viral related functions implicated in disease shock events. Four VGP and three MXP main antigenic epitopes identified, differentially showed high frequency to two MHC class I types. The same pattern was observed for VGP and MXP antigenic epitopes predicted to MHC class II allele variants, favoring high transmission intensity values within the host population, suggesting their involvement in Ebola epidemic upsurges. Related Ebola species with high transmission values were dominantly non-Zaire Ebolaviruses whose antigenic regions showed several repeats, implicating them in viral antigenic variations. Our analysis show that VGP and MXP are both critical for viral entry and pathogenicity in the host and with their species specific occurrence, their combined role in drug/vaccine design is critical. The identification of several antigenic epitopes in this study will be used in combination for drug/vaccine design and for better understanding related molecular targets in pathogenic pathways favoring Ebola disease burden. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> Ebolavirus, pathogenicity, transmission, Major histocompatibility complex (MHC), Immune epitopes, protein interactions </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Daniel Achinko (<a href="mailto:achdany@yahoo.co.uk">achdany@yahoo.co.uk</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Daniel Achinko </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> No competing interests were disclosed. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp;  2015 Achinko D and Dormer A. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Data associated with the article are available under the terms of the <a href="http://creativecommons.org/publicdomain/zero/1.0/" target=_blank data-test-id=box-data-licence-link>Creative Commons Zero "No rights reserved" data waiver</a> (CC0 1.0 Public domain dedication). </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Achinko D and Dormer A. Epitope specificity and protein signaling interactions driving epidemic occurrences of Ebola disease [version 1; peer review: peer review discontinued]</span>. <i>F1000Research</i> 2015, <b>4</b>:166 (<a href="https://doi.org/10.12688/f1000research.6515.1" target=_blank>https://doi.org/10.12688/f1000research.6515.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 24 Jun 2015, <b>4</b>:166 (<a href="https://doi.org/10.12688/f1000research.6515.1" target=_blank>https://doi.org/10.12688/f1000research.6515.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 24 Jun 2015, <b>4</b>:166 (<a href="https://doi.org/10.12688/f1000research.6515.1" target=_blank>https://doi.org/10.12688/f1000research.6515.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d24891e173>Introduction</h2><p class="" id=d24891e176>Ebolavirus is responsible for explosive though rare outbreaks of haemorrhagic fever common in equatorial Africa. The virus is transmitted from person to person through infected body fluids such as faeces, vomit and blood (<a href="#ref-17">Dowell <i>et al.</i>, 1999</a>). Ebolavirus comprises mainly of four subtypes; Zaire, Sudan, Cote dIvoire and Reston. Ebola ancestors are not clearly defined, though Marburg virus, which belongs in the same family as Ebola (Filoviridae; a grouping consisting of nonsegmented, negative-stranded RNA viruses) is a possible ancestor (<a href="#ref-48">Mayo &amp; Pringle, 1998</a>; <a href="#ref-62">Sanchez <i>et al.</i>, 1993</a>).</p><p class="" id=d24891e194>The average rate of case fatalities due to Ebolavirus is 78% (<a href="#ref-41">Kuhn, 2008</a>). The Ebola outbreak in 2014 was considered the largest in history and estimates show about 2,473 infections with 1350 deaths occurring (WHO). The 2014 outbreak was first identified in February in Guinea, West Africa (<a href="#ref-12">Burke, 2003</a>), then in March it spread into Liberia, to Sierra Leone in May and finally to Nigeria towards the end of July. This outbreak was considered the largest because of its exponential expansion, doubling every 34.8 days. In major cities such as Conakry (Guinea), Monrovia (Liberia), Freetown (Sierra Leone) and Lagos (Nigeria) where viral emergence was observed, the spectre of local and international viral dissemination was raised.</p><p class="" id=d24891e203>Currently, no approved drugs have been identified against Ebolavirus disease, though rapid diagnosis, intensive care and support is playing a major role in improving survival. Characteristics of the Ebola disease include; high fever, headache, body aches, intense weakness, stomach pain, and lack of appetite. Manifestations of Ebola in patients are: vomiting, diarrhea, rash, impaired kidney and liver function and for critical cases, external and internal bleeding (<a target=xrefwindow href="http://www.nih.gov/news/health/aug2014/od-29.htm" id=d24891e205>http://www.nih.gov/news/health/aug2014/od-29.htm</a>).</p><p class="" id=d24891e209>The current Ebola epidemic raised awareness worldwide given its international transmission observed in the US and Spain. Several genetic approaches to understanding the disease are currently being tested, the majority investigating the genomic composition of the virus, pathogenic pathways within the host and immune variants (MHC-HLA class I &amp; II) commonly expressed by Ebola disease survivors and non-survivors (<a href="#ref-71">Sullivan <i>et al.</i>, 2003</a>). The HIV, ENV glycoprotein (gp160) and Ebola virus envelope glycoprotein (VGP) are genetically closely related hence, on disrupting the glycoprotein transmembrane domain of MHC class I at the cell surface, a facilitated viral evasion of the immune system was observed (<a href="#ref-58">Ploegh, 1998</a>). This viral interaction at the cell surface is considered to occur with the CD209 antigen (DC-SIGN), making the VGP a prominent area of research for drug/vaccine development.</p><p class="" id=d24891e222>The Ebolavirus genome is 19 kb in length, with seven open reading frames that encode structural proteins including virion envelope glycoprotein (VGP), nucleoprotein (NP), and matrix proteins VP24 and VP40; nonstructural proteins, including VP30 and VP35; and the viral polymerase (<a href="#ref-61">Sanchez <i>et al.</i>, 2001</a>). Unlike the Marburg virus, the GP open reading frame of Ebolavirus has two gene products, a soluble 60- to 70-kDa protein (sGP) and a full-length 150- to 170-kDa protein (GP) that inserts into the viral membrane (<a href="#ref-63">Sanchez <i>et al.</i>, 1996</a>; <a href="#ref-76">Volchkov <i>et al.</i>, 1995</a>), through transcriptional editing.</p><p class="" id=d24891e243>The adaptive immune and inflammatory systems both respond to viral infection synchronously, such that some types of cells (e.g.: monocytes and macrophages) become principal targets for disease pathogenesis. This infection criteria was first suggested based on observations of Ebolavirus immunohistochemical localization <i>in vivo</i>, therefore, mononuclear phagocytes (monocytes and macrophages), endothelial cells, and hepatocytes constitute the main infectious targets (<a href="#ref-4">Baskerville <i>et al.</i>, 1978</a>; <a href="#ref-5">Baskerville <i>et al.</i>, 1985</a>). The recognition of specific Ebolavirus VGP epitopes by monoclonal antibodies conveyed immune protection in a murine model (<a href="#ref-79">Wilson <i>et al.</i>, 2000</a>) and in guinea pigs (<a href="#ref-57">Parren <i>et al.</i>, 2002</a>) infected with Ebolavirus.</p><p class="" id=d24891e273>From the current information known about viral interaction with host genes and pathways favoring cytokine activation, this study was undertaken to analyze the relationship between predicted viral antigenic epitopes and their population frequency as a means of transmission risk. This Ebola species-epitope variation was used to decipher viral species diversity and their related pathway, and how this interplay favors disease intensity within the host. The different viral epitopes identified in this study and their related immune peptides served as a means for predicting which viral species could be commonly found in a given Ebolavirus epidemic. This study opens up epidemiological aspects of viral pathogenesis and possible targets for drug/vaccine design.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d24891e279>Results</h2><div class=section><a name=d24891e282 class=n-a></a><h3 class=section-title>Phylogenetic analysis</h3><p class="" id=d24891e287>The sequence alignment for all retrieved protein variants of different Ebola sequences showed a 1.3% identity across all sequences and a 14.8% pairwise identity across amino acid residues for all sites. These values further improved for each genomic variant analysed for all Ebola species as follows: 23.3% identity across all sites and 68.8% pairwise identity for nuclear proteins, 17.5% identity across all sites and 57.2% pairwise identity for virion glycoproteins and 23.9% identity across all sites and 70.6% pairwise identity respectively for matrix proteins. The phylogenetic analysis showed two main clusters (<a href="#f1">Figure 1A</a>) of nuclear proteins on one arm (blue cluster) and the other arm contained glycoproteins in a sub cluster (red), and matrix proteins in another sub cluster (blue). Mammalian related immune protein sequences associated with viral antigenicity composed the rest of the sequences. The red sub cluster described above was further subjected to phylogenetic analysis and four sub clusters were identified (<a href="#f1">Figure 1B</a>) with the red composed of the Zaire Ebolavirus (29 variants), the black composed of the Reston Ebolavirus (14 variants) the green composed of the Sudan Ebola virus (11 variants) and the blue composed of Bundibugyo and Ta forest Ebola viruses (8 variants as indicated by the name) (<a href="#T1">Table 1</a>). The Marburg virus separated independently and appears to be the ancestral strain from which Ebolaviruses diverged. The host-virus phylogenetic clustering based on related functional sequence features associated with viral genomic structures.</p><div class="fig panel clearfix"><a name=f1 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/6991/d2aac8e7-2e44-410c-8a3f-8d72e6559237_figure1.gif"><img alt="d2aac8e7-2e44-410c-8a3f-8d72e6559237_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/6991/d2aac8e7-2e44-410c-8a3f-8d72e6559237_figure1.gif"></a><div class=caption><h3>Figure 1. Functional-Phylogenetic analysis of Ebola species.</h3><p id=d24891e309>348 amino acid sequences for Ebolavirus species and mammals were aligned and their phylogeny on the unrooted tree showed two distinct clades (<b>1A</b>) wherein the blue cluster belonged to nuclear protein sequences of the viral species while the other cluster contained viral glycoprotein sequences (red sub cluster) and viral matrix proteins (green sub cluster) and the rest were dominantly mammalian proteins. <b>1B</b>) The viral glycoproteins were subjected to further phylogenetic analysis and the unrooted tree showed four main clusters belonging to different species as follows; the red composed of Zaire Ebolavirus (29 variants), the black composed of the Reston Ebolavirus (14 variants) the green composed of the Sudan Ebolavirus (11 variants) and the blue composed of Bundibugyo and Ta forest Ebolaviruses (8 variants).</p></div></div><div class="table-wrap panel clearfix"><a name=T1 class=n-a></a><div class=caption><h3>Table 1. Distribution of sequence variants for viral glycoprotein genes within Ebola species extracted from UniProtKB.</h3><p id=d24891e332>29 variants were identified for Zaire Ebolavirus, 14 variants for Reston Ebolavirus, 11 for Sudan Ebolavirus, 3 variants for Bundibugyo Ebolavirus (B) and 5 variants for Ta forest Ebolavirus (T).</p></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d24891e336 class=n-a></a><thead><a name=d24891e338 class=n-a></a><tr><a name=d24891e340 class=n-a></a><th align=left colspan=1 rowspan=1 valign=bottom><a name=d24891e342 class=n-a></a>Zaire Ebolavirus</th><th align=left colspan=1 rowspan=1><a name=d24891e345 class=n-a></a>Reston<br class=br>Ebolavirus</th><th align=left colspan=1 rowspan=1><a name=d24891e350 class=n-a></a>Bundibugyo &amp; Tai<br class=br>forest Ebolavirus</th><th align=left colspan=1 rowspan=1 valign=bottom><a name=d24891e355 class=n-a></a>Sudan Ebolavirus</th></tr></thead><tbody><a name=d24891e360 class=n-a></a><tr><a name=d24891e362 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e364 class=n-a></a>VGP_EBOZM</td><td colspan=1 rowspan=1><a name=d24891e367 class=n-a></a>VSSGP_EBORE</td><td colspan=1 rowspan=1><a name=d24891e370 class=n-a></a>B8XCN2_9MONO (<b>B</b>)</td><td colspan=1 rowspan=1><a name=d24891e376 class=n-a></a>VSGP_EBOSU</td></tr><tr><a name=d24891e380 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e382 class=n-a></a>VGP_EBOZ5</td><td colspan=1 rowspan=1><a name=d24891e385 class=n-a></a>VSGP_EBORS</td><td colspan=1 rowspan=1><a name=d24891e388 class=n-a></a>VGP_TAFVC (<b>T</b>)</td><td colspan=1 rowspan=1><a name=d24891e394 class=n-a></a>I7FLM2_9MONO</td></tr><tr><a name=d24891e398 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e400 class=n-a></a>VSSGP_EBOZM</td><td colspan=1 rowspan=1><a name=d24891e403 class=n-a></a>C6G8F3_EBORE</td><td colspan=1 rowspan=1><a name=d24891e406 class=n-a></a>VSGP_TAFVC (<b>T</b>)</td><td colspan=1 rowspan=1><a name=d24891e412 class=n-a></a>I7F2J9_9MONO</td></tr><tr><a name=d24891e416 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e418 class=n-a></a>VSGP_EBOZM</td><td colspan=1 rowspan=1><a name=d24891e421 class=n-a></a>C6G8E5_EBORE</td><td colspan=1 rowspan=1><a name=d24891e424 class=n-a></a>B8XCP0_9MONO (<b>T</b>)</td><td colspan=1 rowspan=1><a name=d24891e430 class=n-a></a>VSGP_EBOSM</td></tr><tr><a name=d24891e434 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e436 class=n-a></a>A0A068J471_9MONO</td><td colspan=1 rowspan=1><a name=d24891e439 class=n-a></a>C6G8D6_EBORE</td><td colspan=1 rowspan=1><a name=d24891e442 class=n-a></a>B8XCN9_9MONO (<b>T</b>)</td><td colspan=1 rowspan=1><a name=d24891e448 class=n-a></a>B0LPL7_9MONO</td></tr><tr><a name=d24891e453 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e455 class=n-a></a>X5H5A9_9MONO</td><td colspan=1 rowspan=1><a name=d24891e458 class=n-a></a>C6G8F2_EBORE</td><td colspan=1 rowspan=1><a name=d24891e461 class=n-a></a>B8XCN0_9MONO (<b>B</b>)</td><td colspan=1 rowspan=1><a name=d24891e467 class=n-a></a>VGP_EBOSU</td></tr><tr><a name=d24891e471 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e473 class=n-a></a>A9QPL9_9MONO</td><td colspan=1 rowspan=1><a name=d24891e476 class=n-a></a>VSSGP_EBORR</td><td colspan=1 rowspan=1><a name=d24891e479 class=n-a></a>B8XCN1_9MONO (<b>B</b>)</td><td colspan=1 rowspan=1><a name=d24891e485 class=n-a></a>B0LPL8_9MONO</td></tr><tr><a name=d24891e489 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e491 class=n-a></a>Q6V1Q5_EBOZ5</td><td colspan=1 rowspan=1><a name=d24891e494 class=n-a></a>C6G8D7_EBORE</td><td colspan=1 rowspan=1><a name=d24891e497 class=n-a></a>B8XCP1_9MONO (<b>T</b>)</td><td colspan=1 rowspan=1><a name=d24891e503 class=n-a></a>VGP_EBOSM</td></tr><tr><a name=d24891e507 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e509 class=n-a></a>A0A068J949_9MONO</td><td colspan=1 rowspan=1><a name=d24891e512 class=n-a></a>C6G8E4_EBORE</td><td colspan=1 rowspan=1><a name=d24891e515 class=n-a></a></td><td colspan=1 rowspan=1><a name=d24891e517 class=n-a></a>VGP_EBOSB</td></tr><tr><a name=d24891e521 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e523 class=n-a></a>VSGP_EBOZ5</td><td colspan=1 rowspan=1><a name=d24891e526 class=n-a></a>VSGP_EBORR</td><td colspan=1 rowspan=1><a name=d24891e529 class=n-a></a></td><td colspan=1 rowspan=1><a name=d24891e531 class=n-a></a>VSGP_EBOSB</td></tr><tr><a name=d24891e535 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e537 class=n-a></a>VSGP_EBOEC</td><td colspan=1 rowspan=1><a name=d24891e540 class=n-a></a>VSGP_EBORE</td><td colspan=1 rowspan=1><a name=d24891e543 class=n-a></a></td><td colspan=1 rowspan=1><a name=d24891e545 class=n-a></a>VSSGP_EBOSU</td></tr><tr><a name=d24891e550 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e552 class=n-a></a>V9TJ39_9MONO</td><td colspan=1 rowspan=1><a name=d24891e555 class=n-a></a>VGP_EBORS</td><td colspan=1 rowspan=1><a name=d24891e558 class=n-a></a></td><td colspan=1 rowspan=1><a name=d24891e560 class=n-a></a></td></tr><tr><a name=d24891e563 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e565 class=n-a></a>VGP_EBOEC</td><td colspan=1 rowspan=1><a name=d24891e568 class=n-a></a>VGP_EBORR</td><td colspan=1 rowspan=1><a name=d24891e571 class=n-a></a></td><td colspan=1 rowspan=1><a name=d24891e573 class=n-a></a></td></tr><tr><a name=d24891e576 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e578 class=n-a></a>X5HL92_9MONO</td><td colspan=1 rowspan=1><a name=d24891e581 class=n-a></a>VGP_EBORE</td><td colspan=1 rowspan=1><a name=d24891e584 class=n-a></a></td><td colspan=1 rowspan=1><a name=d24891e586 class=n-a></a></td></tr><tr><a name=d24891e589 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e591 class=n-a></a>A9QPM0_9MONO</td><td colspan=1 rowspan=1><a name=d24891e594 class=n-a></a></td><td colspan=1 rowspan=1><a name=d24891e596 class=n-a></a></td><td colspan=1 rowspan=1><a name=d24891e598 class=n-a></a></td></tr><tr><a name=d24891e601 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e603 class=n-a></a>G8DB49_9MONO</td><td colspan=1 rowspan=1><a name=d24891e606 class=n-a></a></td><td colspan=1 rowspan=1><a name=d24891e608 class=n-a></a></td><td colspan=1 rowspan=1><a name=d24891e610 class=n-a></a></td></tr><tr><a name=d24891e613 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e615 class=n-a></a>G8DB50_9MONO</td><td colspan=1 rowspan=1><a name=d24891e618 class=n-a></a></td><td colspan=1 rowspan=1><a name=d24891e620 class=n-a></a></td><td colspan=1 rowspan=1><a name=d24891e622 class=n-a></a></td></tr><tr><a name=d24891e626 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e628 class=n-a></a>A0A068J9C3_9MONO</td><td colspan=1 rowspan=1><a name=d24891e631 class=n-a></a></td><td colspan=1 rowspan=1><a name=d24891e633 class=n-a></a></td><td colspan=1 rowspan=1><a name=d24891e635 class=n-a></a></td></tr><tr><a name=d24891e638 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e640 class=n-a></a>X5H5I7_9MONO</td><td colspan=1 rowspan=1><a name=d24891e643 class=n-a></a></td><td colspan=1 rowspan=1><a name=d24891e645 class=n-a></a></td><td colspan=1 rowspan=1><a name=d24891e647 class=n-a></a></td></tr><tr><a name=d24891e650 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e652 class=n-a></a>X5HMZ0_9MONO</td><td colspan=1 rowspan=1><a name=d24891e655 class=n-a></a></td><td colspan=1 rowspan=1><a name=d24891e657 class=n-a></a></td><td colspan=1 rowspan=1><a name=d24891e659 class=n-a></a></td></tr><tr><a name=d24891e662 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e664 class=n-a></a>A0A068J419_9MONO</td><td colspan=1 rowspan=1><a name=d24891e667 class=n-a></a></td><td colspan=1 rowspan=1><a name=d24891e669 class=n-a></a></td><td colspan=1 rowspan=1><a name=d24891e671 class=n-a></a></td></tr><tr><a name=d24891e674 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e676 class=n-a></a>A0A068J4A4_9MONO</td><td colspan=1 rowspan=1><a name=d24891e679 class=n-a></a></td><td colspan=1 rowspan=1><a name=d24891e681 class=n-a></a></td><td colspan=1 rowspan=1><a name=d24891e683 class=n-a></a></td></tr><tr><a name=d24891e686 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e688 class=n-a></a>G8DB42_9MONO</td><td colspan=1 rowspan=1><a name=d24891e691 class=n-a></a></td><td colspan=1 rowspan=1><a name=d24891e693 class=n-a></a></td><td colspan=1 rowspan=1><a name=d24891e695 class=n-a></a></td></tr><tr><a name=d24891e699 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e701 class=n-a></a>V9TJ34_9MONO</td><td colspan=1 rowspan=1><a name=d24891e704 class=n-a></a></td><td colspan=1 rowspan=1><a name=d24891e706 class=n-a></a></td><td colspan=1 rowspan=1><a name=d24891e708 class=n-a></a></td></tr><tr><a name=d24891e711 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e713 class=n-a></a>X5HMX4_9MONO</td><td colspan=1 rowspan=1><a name=d24891e716 class=n-a></a></td><td colspan=1 rowspan=1><a name=d24891e718 class=n-a></a></td><td colspan=1 rowspan=1><a name=d24891e720 class=n-a></a></td></tr><tr><a name=d24891e723 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e725 class=n-a></a>VSGP_EBOG4</td><td colspan=1 rowspan=1><a name=d24891e728 class=n-a></a></td><td colspan=1 rowspan=1><a name=d24891e730 class=n-a></a></td><td colspan=1 rowspan=1><a name=d24891e732 class=n-a></a></td></tr><tr><a name=d24891e735 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e737 class=n-a></a>A0A068J941_9MONO</td><td colspan=1 rowspan=1><a name=d24891e740 class=n-a></a></td><td colspan=1 rowspan=1><a name=d24891e742 class=n-a></a></td><td colspan=1 rowspan=1><a name=d24891e744 class=n-a></a></td></tr><tr><a name=d24891e747 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e749 class=n-a></a>VSSGP_EBOZ5</td><td colspan=1 rowspan=1><a name=d24891e752 class=n-a></a></td><td colspan=1 rowspan=1><a name=d24891e754 class=n-a></a></td><td colspan=1 rowspan=1><a name=d24891e756 class=n-a></a></td></tr><tr><a name=d24891e759 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e761 class=n-a></a>VGP_EBOG4</td><td colspan=1 rowspan=1><a name=d24891e764 class=n-a></a></td><td colspan=1 rowspan=1><a name=d24891e766 class=n-a></a></td><td colspan=1 rowspan=1><a name=d24891e768 class=n-a></a></td></tr></tbody></table></div></div><div class=section><a name=d24891e775 class=n-a></a><h3 class=section-title>Protein-protein interaction analysis</h3><p class="" id=d24891e780>The predicted network showed 69 nodes with 123 edges (<a href="#f2">Figure 2</a>). The network analysis distinguished from most important to least important genes (nodes) depicted by name size (<a href="#f2">Figure 2</a>). The three most important nodes in descending order included: GRB2 (Growth factor receptor bound protein 2), IKKE (Inhibitor of nuclear factor kappa-B Kinase subunit epsilon) and UBIQ/UBB (Polyubiquitin-B). Plotting neighborhood connectivity (number of neighbors per node) against clustering coefficient (CC) [ratio of connected edges N for neighbors of node n compared to the maximum number of edges M for node n (N/M)] (<a href="#f3">Figure 3</a>), showed that several nodes (n = 16) did not cluster but had several neighbors. The largest cluster had a coefficient of 0.15 to 0.30. The node distribution based on the best-fit line (4.346 = 8.858x) showed a correlation value of r<sup>2</sup> = 0.319 indicating skewedness towards most connected nodes. Based on all GO molecular functions derived from the network, focus was laid on those genes involved with immune and virus related functions which were; LCK (a tyrosine-protein kinase) and CD209 (a pathogen recognition receptor) respectively. LCK associated functions included: protein kinase activity (GO 4672, P-value = 1.9585E-9) (<a href="#f5">Figure 5B</a>), interspecies interaction between organisms (GO 44419, P-value = 1.3293E-7), T cell activation (GO 42110, P-value = 1.1774E-4), receptor binding (GO 5102, P-value = 7.5709E-3), SH2 domain binding (GO 42169, P-value = 1.2270E-2), CD8 receptor binding (GO 42610, P-value = 1.5663E-2) and CD4 receptor binding (GO 42609, P-value = 2.5648E-2). CD209 associated functions included; Intracellular virion transport (GO 46795, P-value = 2.5648E-2), endocytosis (GO 6897 P-value = 1.1185E-2), signal transducer (GO: 4871, P-value = 1.1671E-2), peptide antigen transport (GO 46968, P-value = 3.4042E-2) and peptide binding (GO 42277, P-value = 4.4976E-2). The protein kinase pathway associated with LCK, showed two clusters of interacting proteins (<a href="#f4">Figure 4A</a>) with the largest (9 genes) containing LCK while that for peptide binding associated with CD209, showed non-interacting proteins (<a href="#f4">Figure 4B</a>). Three proteins, Bone marrow stromal antigen (BST2), Serine/threonine-protein kinase (TBK1) and Interferon regulatory factor 3 (IRF3), had as function, response to virus (GO 9615, P-value = 2.4498E-2) and of the three, TBK1 was identified in the protein kinase pathway. Two viral related proteins identified on the network were ENV [envelope glycoprotein gp160 for the HIV-1 virus which binds to CD4 cells (GO 19031, P-value = 4.0529E-2)] and VP40 (virus matrix protein, a structural protein most commonly found in Ebolavirus and promotes virus assembly and budding) though both showed no protein interactions. Identification of regulatory elements targeting the network showed that, 66 drugs have been developed as targets for several genes within the network, of which proto-oncogene tyrosine-protein kinase (src) and LCK ranked first and second respectively. A few transcription factors like; signal transducer and activator of transcription 1-alpha/beta (STAT1), T-cell leukemia homeobox protein 1 (TLX1), transcription factor PU.1 (SPI1), cyclin dependent kinase inhibitor 1A, and cyclin-dependent kinase inhibitor 1A (CDKN1A), regulated genes including nuclear factor NF--B p105 subunit (NFKB1), p100 subunit (NFKB2), CD209 and SRC respectively (<a href="#f5">Figure 5D</a>). Several microRNA molecules (n = 1399) targeting several genes within the network, mapped to different disease pathways with the most important being hsa05131 (pathogenic <i>Escherichia coli</i> infection) and hsa01430 (cell communication) while major pathway gene related domains were; IPR001664 (intermediate filament protein) and IPR000108 (neutrophil cytosol factor 2).</p><div class="fig panel clearfix"><a name=f2 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/6991/d2aac8e7-2e44-410c-8a3f-8d72e6559237_figure2.gif"><img alt="d2aac8e7-2e44-410c-8a3f-8d72e6559237_figure2.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/6991/d2aac8e7-2e44-410c-8a3f-8d72e6559237_figure2.gif"></a><div class=caption><h3>Figure 2. Ebolavirus protein interaction and pathway analysis.</h3><p id=d24891e821><b>A</b>) The 348 extracted sequences were used to predict a protein interaction map with 69 nodes and 123 edges. Several mammalian sequences captured on the network showed direct interactions with each other with one main protein (LCK) a tyrosine kinase was involved with virus interactions and signalling functions. Name size related to number of interactions each protein had within the network. Two viral proteins were captured in the network; VP40 a matrix protein and ENV a glycoprotein. The red node at top of the network interacting with several other nodes represents a cluster of microRNAs within the network and their related genes they regulate based on their interactions. <b>B</b>) Several regulatory elements were seen to interact with the nodes of interest (red circles). MiRNAs (yellow squares), drug targets (purple squares), transcription factors (light green squares).</p></div></div><div class="fig panel clearfix"><a name=f3 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/6991/d2aac8e7-2e44-410c-8a3f-8d72e6559237_figure3.gif"><img alt="d2aac8e7-2e44-410c-8a3f-8d72e6559237_figure3.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/6991/d2aac8e7-2e44-410c-8a3f-8d72e6559237_figure3.gif"></a><div class=caption><h3>Figure 3. Neighborhood connectivity and clusterization analysis of the protein interactome.</h3><p id=d24891e843>This graph shows that several genes had neighbors up to 14 proteins but no clusters were formed due to no interactions. For those that clustered, majority were between 0.15 and 0.30 defining a high zone of interacting genes within cells.</p></div></div><div class="fig panel clearfix"><a name=f4 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/6991/d2aac8e7-2e44-410c-8a3f-8d72e6559237_figure4.gif"><img alt="d2aac8e7-2e44-410c-8a3f-8d72e6559237_figure4.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/6991/d2aac8e7-2e44-410c-8a3f-8d72e6559237_figure4.gif"></a><div class=caption><h3>Figure 4. Pathways and clusterization observed for viral related genes.</h3><p id=d24891e860><b>A</b>) for the several pathways identified with LCK, protein kinase pathway showed three clusters (blue nodes) with LCK involved in the largest cluster (9 genes). <b>B</b>) The peptide binding cluster (brown nodes) involving CD209 a pathogen recognition receptor gene showed no direct interactions between each other.</p></div></div><div class="fig panel clearfix"><a name=f5 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/6991/d2aac8e7-2e44-410c-8a3f-8d72e6559237_figure5.gif"><img alt="d2aac8e7-2e44-410c-8a3f-8d72e6559237_figure5.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/6991/d2aac8e7-2e44-410c-8a3f-8d72e6559237_figure5.gif"></a><div class=caption><h3>Figure 5. Analysis of peptide antigenicity of viral sequences and their related frequency within a host population.</h3><p id=d24891e883>Antigenic epitopes were predicted for MHC class I and MHC class II. Four (<b>A</b>) against three (<b>B</b>) epitopes for VCP and MXP respectively were validated for MHC class I alleles, 221 (<b>C</b>) against 154 (<b>D</b>) epitopes for VGP and MXP respectively were validated for MHC class II HLA-DRB1 alleles and 41 (<b>E</b>) against 11 (<b>F</b>) epitopes for VGP and MXP respectively were validated for MHC class II HLA-DQA-B alleles. Generally their peptide antigenicity was higher that host population frequency.</p></div></div></div><div class=section><a name=d24891e910 class=n-a></a><h3 class=section-title>Epitope prediction and MHC HLA class I &amp; II allele distribution among Ebolavirus species</h3><p class="" id=d24891e915>The most antigenic epitopes for each virus structural proteins (glycoproteins and matrix proteins) were statistically evaluated for their peptide antigenic score against peptide frequency (count) for the HLA allele types (<a href="#f5">Figure 5AF</a>). For HLA type I, the VGP epitope peptides showed t = 0.24338 while the MXP proteins showed t = 0.09190. For the HLA type II (HLA-DRB alleles), the VGP showed t = 2.8506E-107 while the MXP showed t = 2.21965E-49 and for HLA type II (HLA-DQA-A alleles), the VGP showed t = 8.96323E-08 while the MXP showed t = 0,046921205. For HLA class I alleles, four main epitopes (FLLQLNETI, FLTNTIRGV, FQVDHLTYV and NMTNFLFQV) were predicted for VGP while three main epitopes (AIMLASYTV, ALLTGSYTI and LTMVITPDY) were predicted for MXP. Both viral structural proteins showed high frequency values for HLA*A02:01 and HLA*A02:02 alleles (<a href="#f6">Figure 6A</a>, <a href="#TS2">Table S2</a>) with VGP higher for the latter than the former and vice versa for MXP. The validated epitopes for VGP showed that; FLLQLNETI was specific to HLA*A02:02 while FQVDHLTYV and NMTNFLFQV was variably distributed for all the selected HLA class I alleles (<a href="#f6">Figure 6B</a>). The validated epitopes for MXP showed that; AIMLASYTV was variably distributed for selected HLA class I alleles while ALLTGSYTI and LTMVITPDY were allele specific (<a href="#f6">Figure 6C</a>). FLLQLNETI was specific to Zaire Ebolavirus with a unique occurrence while the other epitopes were either specific or distributed among Bundibugyo and Ta forest Ebolaviruses with multiple occurrences (<a href="#f6">Figure 6D</a>). AIMLASYTV was more specific to Reston and Sudan Ebolaviruses with multiple occurrences while the other epitopes were either specific to Sudan Ebolavirus or Marburg virus with unique occurrences (<a href="#f6">Figure 6E</a>).</p><div class="fig panel clearfix"><a name=f6 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/6991/d2aac8e7-2e44-410c-8a3f-8d72e6559237_figure6.gif"><img alt="d2aac8e7-2e44-410c-8a3f-8d72e6559237_figure6.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/6991/d2aac8e7-2e44-410c-8a3f-8d72e6559237_figure6.gif"></a><div class=caption><h3>Figure 6. MHC class I alleles distribution for antigenic epitopes and different viral species.</h3><p id=d24891e950>Frequency of antigenic peptides for both VGP and MXP were dominant for HLA*A02:01 and HLA*A02:02 alleles (<b>A</b>) with VGP frequency higher in the latter than in the former and vice versa. Epitope distribution for the different immune alleles showed that antigenic sites for each genomic structure (VGP and MXP) could be recognised by particular immune alleles while others were recognized by all (<b>B</b>, VGP and <b>C</b>, MXP). The identified epitopes were seen to occur variably among species with some epitopes being specific to a given viral specie and others common to a species (<b>D</b>, VGP and <b>E</b>, MXP).</p></div></div><p class="" id=d24891e972>Several epitopes were predicted for HLA class II-DRB alleles; VGP (n = 221) and MXP (n = 154) showing high frequencies for DRB1*01:01 and DRB1*01:04 alleles (<a href="#f7">Figure 7A</a>, <a href="#TS3">Table S3</a>) with MXP higher for the latter than the former and vice versa for VGP. The four epitopes with highest VGP frequencies and coverage (COV) per HLA-DRB1 allele were; IILFQRTFSIPLGVI (7.05%) &amp; COV = 6/8, RWGFRSGVPPKVVNY (3.52%) &amp; COV = 3/8, WVIILFQRTFSIPLG (3.52%) &amp; COV = 3/8 and IILFQRAISMPLGIV (3.40%) &amp; COV = 6/8 (<a href="#f7">Figure 7B</a>). The four epitopes with the highest MXP frequencies and coverage per HLA-DRB1 allele were; PQYFTFDLTALKLIT (7.25%) &amp; COV = 5/8, ITHFGKATNPLVRVN (4.38%) &amp; COV = 5/8, TTAAIMLASYTITHF (3.00%) &amp; COV = 2/8 and QKTYSFDSTTAAIML (2.75%) &amp; COV = 2/8 (<a href="#f7">Figure 7C</a>). Based on VGP and HLA-DRB1 allele epitope distribution per Ebola species; IILFQRTFSIPLGVI was dominantly Zaire Ebolavirus, WVIILFQRTFSIPLG and RWGFRSGVPPKVVNY were solely Zaire Ebolavirus and IILFQRAISMPLGIV was dominantly Reston Ebolavirus (<a href="#f7">Figure 7D</a>). For the MXP epitopes and HLA_DRB1 allele distribution per Ebola species; PQYFTFDLTALKLIT was relatively equally distributed among the different Ebolaviruses, ITHFGKATNPLVRVN was solely Zaire Ebolavirus, TTAAIMLASYTITHF and QKTYSFDSTTAAIML were dominantly Zaire Ebolavirus (<a href="#f7">Figure 7E</a>).</p><div class="fig panel clearfix"><a name=f7 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/6991/d2aac8e7-2e44-410c-8a3f-8d72e6559237_figure7.gif"><img alt="d2aac8e7-2e44-410c-8a3f-8d72e6559237_figure7.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/6991/d2aac8e7-2e44-410c-8a3f-8d72e6559237_figure7.gif"></a><div class=caption><h3>Figure 7. MHC class II HLA-DRB1 allele distribution for antigenic epitopes and different viral species.</h3><p id=d24891e1004>Frequency of antigenic peptides for both VGP and MXP were dominant for DRB1*01:01 and DRB1*01:04 alleles (<b>A</b>) with VGP frequency higher in the former than in the latter and vice versa. For the top four selected Epitopes, frequency distribution for the different immune alleles showed that antigenic sites for each genomic structure (VGP and MXP) could be recognised by particular immune alleles, others were recognized by all and some could not be recognized by any of the immune alleles (<b>B</b>, VGP and <b>C</b>, MXP). The identified epitopes were seen to occur variably among species with some epitopes being specific to a given viral specie and several others common to a species and for some species, none had the epitope site (<b>D</b>, VGP and <b>E</b>, MXP).</p></div></div><p class="" id=d24891e1027>Several epitopes were predicted for HLA class II-DQA-B alleles; VGP (n = 41) and MXP (n = 11) showing high frequencies for HLA-DQA1_03_01-DQB1_03_01 and HLA-DQA1_05_04-DQB1_05_03 (<a href="#f8">Figure 8A</a>, <a href="#TS4">Table S4</a>) with VGP higher for the former than for the latter. The four epitopes with highest VGP frequencies per HLA-DQA-B allele coverage were; ETEYLFEVDNLTYVQ (13.55%) &amp; COV = 3/9, FHKEGAFFLYDRLAS (8.64%) &amp; COV = 1/9, RGVNFAEGVIAFLIL (7.24%) &amp; COV = 3/9 and WVIILFQRTFSIPLG (6.78%) and COV = 1/9 (<a href="#f8">Figure 8B</a>). The four epitopes with highest MXP frequencies per HLA-DQA-B allele coverage were; YSFDSTTAAIMLASY (33.33%) &amp; COV = 2/7, HTPSGVASAFILEAT (33.33%) &amp; COV = 5/7, IYSFDSTTAAIMLAS (8.33%) &amp; COV = 1/7 and HTPSGVASAFILEAK (8.33%) &amp; COV = 4/7 (<a href="#f8">Figure 8C</a>). Based on VGP epitope and HLA-DQA-B distribution per Ebola species; ETEYLFEVDNLTYVQ and FHKEGAFFLYDRLAS was dominantly Zaire Ebolavirus, RGVNFAEGVIAFLIL was dominantly Sudan and Reston Ebolaviruses and WVIILFQRTFSIPLG was solely Zaire Ebolavirus (<a href="#f8">Figure 8D</a>). Based on MXP epitope and HLA-DQA-B distribution per Ebola species; YSFDSTTAAIMLASY was relatively distributed equally among the different Ebolaviruses, HTPSGVASAFILEAT was dominantly Reston Ebolavirus, IYSFDSTTAAIMLAS was solely Reston Ebolavirus and HTPSGVASAFILEAK was equally distributed between Reston and Ta Ebolaviruses (<a href="#f8">Figure 8E</a>).</p><div class="fig panel clearfix"><a name=f8 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/6991/d2aac8e7-2e44-410c-8a3f-8d72e6559237_figure8.gif"><img alt="d2aac8e7-2e44-410c-8a3f-8d72e6559237_figure8.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/6991/d2aac8e7-2e44-410c-8a3f-8d72e6559237_figure8.gif"></a><div class=caption><h3>Figure 8. MHC class II HLA-DQA-B allele distribution for antigenic epitopes and different viral species.</h3><p id=d24891e1059>Frequency of antigenic peptides for both VGP and MXP were dominant for HLA-DQA1_05_04-DQB1_05_03 allele with that of VGP higher than MXP but only MXP presented a high frequency for HLA-DQA1_03_01-DQB1_03_01 allele (<b>A</b>). For the top four selected epitopes, frequency distribution for the different immune alleles showed that antigenic sites for each genomic structure (VGP and MXP) could be recognised by particular immune alleles, others were recognized by all and some could not be recognized by any of the immune alleles (<b>B</b>, VGP and <b>C</b>, MXP). The identified epitopes were seen to occur variably among species with some epitopes being specific to a given viral specie and several others common to a species and for some species, none had the epitope site (<b>D</b>, VGP and <b>E</b>, MXP).</p></div></div></div><div class=section><a name=d24891e1082 class=n-a></a><h3 class=section-title>Prediction of transmission intensity (TRI) values in the wake of Ebola epidemic</h3><p class="" id=d24891e1087>Based on the data collected, peptide scores and peptide frequencies expressed in the viral population (simulating host population) were used to calculate the transmission intensity ratio predicting how fast or slow the virus will spread within its host population (<a href="#T2">Table 2</a>). The majority of the MHC HLA class I peptides showed a value greater than 1 while the majority of the MHC HLA class II peptides showed a value less than one. In general, TRI &lt; 1, showed multiple expressed epitopes within each species and high distribution within the population and vice versa for TRI &gt; 1. Zaire and Reston Ebolaviruses showed the lowest TRIs in the selected data.</p><div class="table-wrap panel clearfix"><a name=T2 class=n-a></a><div class=caption><h3>Table 2. Transmission intensity values for Ebola disease.</h3><p id=d24891e1103>Epitopes predicted for MHC class I and II were predicted and their antigenic scores (PS)/peptide frequency within the host population were analyzed to determine values which could be used to determine epidemic outcomes of the disease. PS/PF &gt; 1 was considered high transmission risk value. M = mixed, S = specific.</p></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d24891e1107 class=n-a></a><thead><a name=d24891e1109 class=n-a></a><tr><a name=d24891e1111 class=n-a></a><th colspan=1 rowspan=1><a name=d24891e1113 class=n-a></a></th><th align=left colspan=1 rowspan=1 valign=top><a name=d24891e1115 class=n-a></a>Epitope</th><th align=left colspan=1 rowspan=1 valign=top><a name=d24891e1118 class=n-a></a>Peptide<br class=br>antigenic<br class=br>score (PS)</th><th align=left colspan=1 rowspan=1 valign=top><a name=d24891e1125 class=n-a></a>Peptide<br class=br>frequency<br class=br>(PF)</th><th align=left colspan=1 rowspan=1 valign=top><a name=d24891e1132 class=n-a></a>TRI = PS/PF</th><th align=left colspan=1 rowspan=1 valign=top><a name=d24891e1136 class=n-a></a>Species<br class=br>(Ebolavirus)</th></tr></thead><tbody><a name=d24891e1143 class=n-a></a><tr><a name=d24891e1145 class=n-a></a><td colspan=1 rowspan=4><a name=d24891e1147 class=n-a></a>HLA-class I<br class=br>VGP</td><td colspan=1 rowspan=1><a name=d24891e1152 class=n-a></a>FLLQLNETI</td><td align=right colspan=1 rowspan=1><a name=d24891e1155 class=n-a></a>0,604656471</td><td align=right colspan=1 rowspan=1><a name=d24891e1158 class=n-a></a>1</td><td align=right colspan=1 rowspan=1><a name=d24891e1161 class=n-a></a>0,604656471</td><td colspan=1 rowspan=1><a name=d24891e1165 class=n-a></a>Zaire (S)</td></tr><tr><a name=d24891e1169 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e1171 class=n-a></a>FLTNTIRGV</td><td align=right colspan=1 rowspan=1><a name=d24891e1174 class=n-a></a>1</td><td align=right colspan=1 rowspan=1><a name=d24891e1177 class=n-a></a>0,074074074</td><td align=right colspan=1 rowspan=1><a name=d24891e1180 class=n-a></a>13,5</td><td colspan=1 rowspan=1><a name=d24891e1183 class=n-a></a>Bundibugyo and<br class=br>Ta forest</td></tr><tr><a name=d24891e1189 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e1191 class=n-a></a>FQVDHLTYV</td><td align=right colspan=1 rowspan=1><a name=d24891e1194 class=n-a></a>0,928897512</td><td align=right colspan=1 rowspan=1><a name=d24891e1197 class=n-a></a>0,888888889</td><td align=right colspan=1 rowspan=1><a name=d24891e1200 class=n-a></a>1,045009701</td><td colspan=1 rowspan=1><a name=d24891e1203 class=n-a></a>Bundibugyo and<br class=br>Ta forest</td></tr><tr><a name=d24891e1209 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e1211 class=n-a></a>NMTNFLFQV</td><td align=right colspan=1 rowspan=1><a name=d24891e1214 class=n-a></a>0,636955033</td><td align=right colspan=1 rowspan=1><a name=d24891e1217 class=n-a></a>0,333333333</td><td align=right colspan=1 rowspan=1><a name=d24891e1220 class=n-a></a>1,910865099</td><td colspan=1 rowspan=1><a name=d24891e1223 class=n-a></a>Bundibugyo and<br class=br>Ta forest</td></tr><tr><a name=d24891e1229 class=n-a></a><td colspan=1 rowspan=3><a name=d24891e1231 class=n-a></a>HLA-class I<br class=br>MXP</td><td colspan=1 rowspan=1><a name=d24891e1236 class=n-a></a>AIMLASYTV</td><td align=right colspan=1 rowspan=1><a name=d24891e1239 class=n-a></a>1</td><td align=right colspan=1 rowspan=1><a name=d24891e1242 class=n-a></a>1</td><td align=right colspan=1 rowspan=1><a name=d24891e1245 class=n-a></a>1</td><td colspan=1 rowspan=1><a name=d24891e1249 class=n-a></a>Reston and Sudan</td></tr><tr><a name=d24891e1254 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e1256 class=n-a></a>ALLTGSYTI</td><td align=right colspan=1 rowspan=1><a name=d24891e1259 class=n-a></a>0,849088454</td><td align=right colspan=1 rowspan=1><a name=d24891e1262 class=n-a></a>0,2</td><td align=right colspan=1 rowspan=1><a name=d24891e1265 class=n-a></a>4,245442269</td><td colspan=1 rowspan=1><a name=d24891e1268 class=n-a></a>Sudan &amp; Marburg</td></tr><tr><a name=d24891e1272 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e1274 class=n-a></a>LTMVITPDY</td><td align=right colspan=1 rowspan=1><a name=d24891e1277 class=n-a></a>0,915091155</td><td align=right colspan=1 rowspan=1><a name=d24891e1280 class=n-a></a>0,3</td><td align=right colspan=1 rowspan=1><a name=d24891e1283 class=n-a></a>3,050303849</td><td colspan=1 rowspan=1><a name=d24891e1286 class=n-a></a>Sudan &amp; Marburg</td></tr><tr><a name=d24891e1290 class=n-a></a><td colspan=1 rowspan=4><a name=d24891e1292 class=n-a></a>HLA-DRB1<br class=br>VGP</td><td colspan=1 rowspan=1><a name=d24891e1297 class=n-a></a>IILFQRTFSIPLGVI</td><td align=right colspan=1 rowspan=1><a name=d24891e1300 class=n-a></a>0,314844562</td><td align=right colspan=1 rowspan=1><a name=d24891e1303 class=n-a></a>1</td><td align=right colspan=1 rowspan=1><a name=d24891e1306 class=n-a></a>0,314844562</td><td colspan=1 rowspan=1><a name=d24891e1310 class=n-a></a>Zaire (M)</td></tr><tr><a name=d24891e1314 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e1316 class=n-a></a>WVIILFQRTFSIPLG</td><td align=right colspan=1 rowspan=1><a name=d24891e1319 class=n-a></a>0,397193612</td><td align=right colspan=1 rowspan=1><a name=d24891e1322 class=n-a></a>0,5</td><td align=right colspan=1 rowspan=1><a name=d24891e1325 class=n-a></a>0,794387225</td><td colspan=1 rowspan=1><a name=d24891e1328 class=n-a></a>Zaire (S)</td></tr><tr><a name=d24891e1332 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e1334 class=n-a></a>RWGFRSGVPPKVVNY</td><td align=right colspan=1 rowspan=1><a name=d24891e1337 class=n-a></a>0,591798167</td><td align=right colspan=1 rowspan=1><a name=d24891e1340 class=n-a></a>0,5</td><td align=right colspan=1 rowspan=1><a name=d24891e1343 class=n-a></a>1,183596334</td><td colspan=1 rowspan=1><a name=d24891e1346 class=n-a></a>Zaire (S)</td></tr><tr><a name=d24891e1350 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e1352 class=n-a></a>IILFQRAISMPLGIV</td><td align=right colspan=1 rowspan=1><a name=d24891e1355 class=n-a></a>0,326136256</td><td align=right colspan=1 rowspan=1><a name=d24891e1358 class=n-a></a>0,482758621</td><td align=right colspan=1 rowspan=1><a name=d24891e1361 class=n-a></a>0,675567959</td><td colspan=1 rowspan=1><a name=d24891e1364 class=n-a></a>Reston</td></tr><tr><a name=d24891e1369 class=n-a></a><td colspan=1 rowspan=4><a name=d24891e1371 class=n-a></a>HLA-DRB1<br class=br>MXP</td><td colspan=1 rowspan=1><a name=d24891e1376 class=n-a></a>PQYFTFDLTALKLIT</td><td align=right colspan=1 rowspan=1><a name=d24891e1379 class=n-a></a>0,411019225</td><td align=right colspan=1 rowspan=1><a name=d24891e1382 class=n-a></a>1</td><td align=right colspan=1 rowspan=1><a name=d24891e1385 class=n-a></a>0,411019225</td><td colspan=1 rowspan=1><a name=d24891e1389 class=n-a></a>All</td></tr><tr><a name=d24891e1393 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e1395 class=n-a></a>ITHFGKATNPLVRVN</td><td align=right colspan=1 rowspan=1><a name=d24891e1398 class=n-a></a>0,277306412</td><td align=right colspan=1 rowspan=1><a name=d24891e1401 class=n-a></a>0,603448276</td><td align=right colspan=1 rowspan=1><a name=d24891e1404 class=n-a></a>0,45953634</td><td colspan=1 rowspan=1><a name=d24891e1407 class=n-a></a>Zaire (S)</td></tr><tr><a name=d24891e1411 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e1413 class=n-a></a>TTAAIMLASYTITHF</td><td align=right colspan=1 rowspan=1><a name=d24891e1416 class=n-a></a>0,354419504</td><td align=right colspan=1 rowspan=1><a name=d24891e1419 class=n-a></a>0,413793103</td><td align=right colspan=1 rowspan=1><a name=d24891e1422 class=n-a></a>0,856513801</td><td colspan=1 rowspan=1><a name=d24891e1425 class=n-a></a>Zaire (M)</td></tr><tr><a name=d24891e1429 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e1431 class=n-a></a>QKMYSFDSTTAAIML</td><td align=right colspan=1 rowspan=1><a name=d24891e1434 class=n-a></a>0,360970895</td><td align=right colspan=1 rowspan=1><a name=d24891e1437 class=n-a></a>0,034482759</td><td align=right colspan=1 rowspan=1><a name=d24891e1440 class=n-a></a>10,46815594</td><td colspan=1 rowspan=1><a name=d24891e1443 class=n-a></a>Zaire (M)</td></tr><tr><a name=d24891e1447 class=n-a></a><td colspan=1 rowspan=4><a name=d24891e1449 class=n-a></a>HLA-DQA-B<br class=br>VGP</td><td colspan=1 rowspan=1><a name=d24891e1454 class=n-a></a>ETEYLFEVDNLTYVQ</td><td align=right colspan=1 rowspan=1><a name=d24891e1457 class=n-a></a>0,333333333</td><td align=right colspan=1 rowspan=1><a name=d24891e1460 class=n-a></a>1</td><td align=right colspan=1 rowspan=1><a name=d24891e1463 class=n-a></a>0,333333333</td><td colspan=1 rowspan=1><a name=d24891e1467 class=n-a></a>Zaire (M)</td></tr><tr><a name=d24891e1471 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e1473 class=n-a></a>FHKEGAFFLYDRLAS</td><td align=right colspan=1 rowspan=1><a name=d24891e1476 class=n-a></a>0,41535682</td><td align=right colspan=1 rowspan=1><a name=d24891e1479 class=n-a></a>0,637931034</td><td align=right colspan=1 rowspan=1><a name=d24891e1482 class=n-a></a>0,65109988</td><td colspan=1 rowspan=1><a name=d24891e1485 class=n-a></a>Zaire (M)</td></tr><tr><a name=d24891e1490 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e1492 class=n-a></a>RGVNFAEGVIAFLIL</td><td align=right colspan=1 rowspan=1><a name=d24891e1495 class=n-a></a>0,427280939</td><td align=right colspan=1 rowspan=1><a name=d24891e1498 class=n-a></a>0,534482759</td><td align=right colspan=1 rowspan=1><a name=d24891e1501 class=n-a></a>0,799428855</td><td colspan=1 rowspan=1><a name=d24891e1504 class=n-a></a>Sudan &amp; Reston</td></tr><tr><a name=d24891e1508 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e1510 class=n-a></a>WVIILFQRTFSIPLG</td><td align=right colspan=1 rowspan=1><a name=d24891e1513 class=n-a></a>0,506293285</td><td align=right colspan=1 rowspan=1><a name=d24891e1516 class=n-a></a>0,5</td><td align=right colspan=1 rowspan=1><a name=d24891e1519 class=n-a></a>1,01258657</td><td colspan=1 rowspan=1><a name=d24891e1522 class=n-a></a>Zaire (S)</td></tr><tr><a name=d24891e1526 class=n-a></a><td colspan=1 rowspan=4><a name=d24891e1528 class=n-a></a>HLA-DQA-B<br class=br>MXP</td><td colspan=1 rowspan=1><a name=d24891e1533 class=n-a></a>YSFDSTTAAIMLASY</td><td align=right colspan=1 rowspan=1><a name=d24891e1536 class=n-a></a>0,439248283</td><td align=right colspan=1 rowspan=1><a name=d24891e1539 class=n-a></a>1</td><td align=right colspan=1 rowspan=1><a name=d24891e1542 class=n-a></a>0,439248283</td><td colspan=1 rowspan=1><a name=d24891e1546 class=n-a></a>All</td></tr><tr><a name=d24891e1550 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e1552 class=n-a></a>HTPSGVASAFILEAT</td><td align=right colspan=1 rowspan=1><a name=d24891e1555 class=n-a></a>0,363570654</td><td align=right colspan=1 rowspan=1><a name=d24891e1558 class=n-a></a>1</td><td align=right colspan=1 rowspan=1><a name=d24891e1561 class=n-a></a>0,363570654</td><td colspan=1 rowspan=1><a name=d24891e1564 class=n-a></a>Reston (M)</td></tr><tr><a name=d24891e1568 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e1570 class=n-a></a>IYSFDSTTAAIMLAS</td><td align=right colspan=1 rowspan=1><a name=d24891e1573 class=n-a></a>0,454644019</td><td align=right colspan=1 rowspan=1><a name=d24891e1576 class=n-a></a>0,25</td><td align=right colspan=1 rowspan=1><a name=d24891e1579 class=n-a></a>1,818576075</td><td colspan=1 rowspan=1><a name=d24891e1582 class=n-a></a>Reston (S)</td></tr><tr><a name=d24891e1586 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e1588 class=n-a></a>HTPSGVASAFILEAK</td><td align=right colspan=1 rowspan=1><a name=d24891e1591 class=n-a></a>0,53552584</td><td align=right colspan=1 rowspan=1><a name=d24891e1594 class=n-a></a>0,25</td><td align=right colspan=1 rowspan=1><a name=d24891e1597 class=n-a></a>2,142103361</td><td colspan=1 rowspan=1><a name=d24891e1600 class=n-a></a>Reston &amp; Ta<br class=br>forest</td></tr></tbody></table></div></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d24891e1613>Discussion</h2><p class="" id=d24891e1616>In this study, Ebolavirus amino acid sequence data was obtained for Zaire, Sudan, Cte d'Ivoire (Ta forest), Uganda (Bundibugyo) and Philippines (Reston) species. These sequences were subjected to phylogenetic analysis, which took into consideration all known functional motifs and domains for each sequence to construct the tree. It was observed that, species variation was higher for VGP compared to Nuclear and Matrix proteins of the viral genome. This observation could have resulted from pairwise alignments, whose identity scores accounted for species specific clustering observed.</p><p class="" id=d24891e1619>The first two Ebolavirus species, Zaire and Sudan, identified in 1976 and later, Reston and Cte d'Ivoire, in 1989 and 1994, respectively, revealed after comparison that the four viral genomes differed from each other by 36.742.3% (<a href="#ref-74">Towner <i>et al.</i>, 2008</a>). In 2008, Uganda Ebolavirus species was identified and its genomic sequence differed from previously known viruses by 31.742.4% (<a href="#ref-74">Towner <i>et al.</i>, 2008</a>). Work done by <a href="#ref-43">Leroy <i>et al.</i> (2002)</a> showed that the mean amino acid distances between the same NP subtypes was about 45%, compared to 6566% in VGP. These values were higher than those observed in this work with probable difference being that we performed an amino acid sequence alignment, whilst the authors carried out a nucleotide sequence alignment. The longest branch on the tree associated with Marburg virus suggest an ancestral lineage which could be a consequence of evolutionary time wherein, Marburg virus and Ebolavirus were isolated in 1967 (<a href="#ref-67">Siegert <i>et al.</i>, 1967</a>) and 1976 (<a href="#ref-10">Bowen <i>et al.</i>, 1977</a>; <a href="#ref-33">Johnson <i>et al.</i>, 1977</a>), respectively. They also show a genomic difference 50% at the nucleotide level (<a href="#ref-73">Towner <i>et al.</i>, 2006</a>). The presence of one gene overlap in Marburg virus compared to several in Ebolavirus delineates the main genomic difference between them (<a href="#ref-41">Kuhn, 2008</a>).</p><p class="" id=d24891e1668>The observed functional relationship between related hosts (mammal) and Ebolavirus proteins, identified within the interactome, showed direct interactions between the former, but none was observed between VP40 and ENV (gp160), and likewise to host proteins. Given the identification of <i>gag</i>, <i>pol</i>, and <i>env</i> (ENV) retroviral genes, the <i>pol</i> gene, which encodes reverse transcriptase (RT), is considered the most conserved of the retroid elements (<a href="#ref-68">Simmons <i>et al.</i>, 2002</a>). The polypeptide encoded by the <i>env</i> gene is cleaved into two proteins; a surface protein for receptor recognition, and a transmembrane subunit, which anchors the ENV complex to the membrane. The ENV transmembrane unit interacts directly with the cell membrane, favoring viral penetration (<a href="#ref-7">Bnit <i>et al.</i>, 2001</a>) into the cell which has been elucidated for human immunodeficiency virus type 1 (HIV-1) (<a href="#ref-15">Connolly <i>et al.</i>, 1999</a>; <a href="#ref-80">Xu <i>et al.</i>, 1998</a>) and Ebolavirus (<a href="#ref-61">Sanchez <i>et al.</i>, 2001</a>). The ENV-dependent pathways for HIV accounts for almost 50% of antigen presentation mediated principally by the lectin DC-SIGN (CD209). CD209 molecules, form part of dendritic cells equipped with molecular diversity for HIV-1 capture, which binds the viral envelope gp120 with high affinity. Efficient cross presentation of HIV antigens from incoming virions activates anti-HIV CD8<sup>+</sup> cytotoxic T lymphocytes. The major role of CD209 in viral entry into the host cell, solidifies its identity within the predicted interactome. Though the observed functional roles include intracellular virion transport, protein signaling and peptide identification, associated with CD209, no direct interaction was observed with the viral structural genes predicted on the network. This could suggest a domain specific function in CD209 for viral-host interactions, and though similar in Ebolaviruses, the functional pathway may be different.</p><p class="" id=d24891e1720>The Ebolavirus VGP is synthesized as a secreted (sGP) or full-length transmembrane form, having distinct biochemical and biological properties. Multiple lines of evidence suggest that VGP plays a prominent role in clinical manifestations of Ebolavirus infection. A change of immune response could result from inhibition of neutrophil activation by sGP, while the transmembrane form could contribute to symptoms of hemorrhagic fever due to viral attack of reticuloendothelial and blood vessel cells (<a href="#ref-70">Strher <i>et al.</i>, 2001</a>; <a href="#ref-83">Yang <i>et al.</i>, 1998</a>). The different host cell targets and roles played by sGP and the transmembrane form, makes them potential targets that could be exploited for control of Ebolaviral burden. The type of preferred cells by each VGP form, should determine the type of pathogenic manifestation and nature of transmission intensity observed within the population. Therefore, drug targets common across viral species or specific to most virulent forms will be vital for quick clearance of an infection.</p><p class="" id=d24891e1736>The assembly and budding of Ebolaviruses from the cell membrane is a process directed by the viral matrix protein, VP40 (<a href="#ref-27">Harty <i>et al.</i>, 2000</a>; <a href="#ref-56">Panchal <i>et al.</i>, 2003</a>). VP40 alone is capable of assembling and budding filamentous virus-like particles from cells (<a href="#ref-22">Geisbert &amp; Jahrling, 1995</a>; <a href="#ref-34">Johnson <i>et al.</i>, 2006</a>; <a href="#ref-52">Noda <i>et al.</i>, 2002</a>). The specific interaction of VP40 with membrane-associated VGP and VP24 during the budding process, is a possible occurrence. Work done by <a href="#ref-9">Bornholdt <i>et al.</i> (2013)</a>, showed that binding of VP40 to RNA forms a ring structure at a perinuclear location. Observation of these rings was only in infected cells, but not mature purified Ebolaviruses (<a href="#ref-23">Gomis-Rth <i>et al.</i>, 2003</a>), which suggests that, the ring structure was not necessary for matrix assembly. Therefore the VP40 RNA-binding rings could possess a critical function within infected cells (<a href="#ref-23">Gomis-Rth <i>et al.</i>, 2003</a>; <a href="#ref-29">Hoenen <i>et al.</i>, 2010</a>). Previous data showed that, recombinant viruses that have an RNA-binding knockout mutation for VP40 (R134A) failed to replicate (<a href="#ref-30">Hoenen <i>et al.</i>, 2005</a>), suggesting a dual role for VP40, which includes: viral transcription with assembly, and budding, for the release of new viral particles. Given that VP40 is structural and shows possible interactions with VGP, suggests a contributory role to host immune activation pathway, and though directing different cellular processes, their immune-interaction makes them potential targets for vaccine design and control of Ebolavirus disease.</p><p class="" id=d24891e1797>The close relationship between Ebola genomic structures; VP40, CD209 and ENV and between HIV-1 and Ebolavirus, motivated our use of VP40 and VGP for the prediction of antigenic peptide epitopes required for generating potent host antibodies against the virus. The interactive nature between ENV and CD209 proteins, could explain the downstream signaling reactions necessary for cytokine activation. Identifying target signaling molecules activated by interaction of CD209 with Ebolavirus antigens, could suggest a possible path for curbing the loss of body fluids during epidemic outbreaks. The presence of LCK and its kinase function suggests a protein signaling role in driving the infection and loss of fluid pathway associated with Ebolavirus. Its involvement in CD4 and CD8 binding makes its pathway, an interesting target area for Ebolavirus disease control. The signaling of T cell receptors (TCR), which results from peptide-MHC binding, requires the phosphorylation of immunoreceptor, tyrosine-based activation motifs (ITAMs) and CD3 complex, associated with SFK Lck (<a href="#ref-55">Palacios &amp; Weiss, 2004</a>). Generally, it is accepted that, the activation of T cells favors Lck activation by pMHC binding. Given the stable association of Lck to CD4 and CD8 coreceptors (<a href="#ref-60">Rudd <i>et al.</i>, 1988</a>; <a href="#ref-75">Veillette <i>et al.</i>, 1988</a>), other interaction models propose that MHC binding activates Lck by trans-autophosphorylation. Basing on this information, the role-played by LCK within the network and its interaction with immune cells becomes very clear. The implication of the LCK gene in Ebolavirus disease intensity could be related to a hyper activation cascade leading to massive release of cytokines (Cytokine storm), which is an event common to patients with septic shock (<a href="#ref-44">Mackenzie &amp; Lever, 2007</a>). The Lck protein kinase pathway identified in the network as a cluster, showed interaction with proteins including SRC (Proto-oncogene tyrosine-protein kinase), MERTK (Tyrosine-protein kinase), TYRO3 (Tyrosine-protein kinase receptor), UFO (Tyrosine-protein kinase receptor), ACK1 (Activated CDC42 kinase 1), BMPR2 (Bone morphogenic protein receptor type-2), YES (Tyrosine-protein kinase) and FYN (tyrosine protein kinase). The UniProt Knowledge Base (KB) (<a target=xrefwindow href="http://www.uniprot.org" id=d24891e1817>www.uniprot.org</a>), associates these proteins to downstream ligand binders and signal transducers, which activates other proteins in a phosphokinase related interaction type. Several of these are involved in disease pathways including SRC (colon carcinoma), MERTK (retinitis pigmentosa, MIM: 613862), UFO (thyroid tumorigenesis) and BMPR2 (pulmonary hypertension primary, PPHL 1, MIM: 178600). This cluster suggests that, the role played by LCK in kinase function and implicates it to epidemic levels observed for Ebolavirus disease.</p><p class="" id=d24891e1821>MiRNAs are potentially known to regulate several proteins (<a href="#ref-26">Grimson <i>et al.</i>, 2007</a>) and also modulate their concentrations in a dose-dependent manner (<a href="#ref-2">Baek <i>et al.</i>, 2008</a>; <a href="#ref-64">Selbach <i>et al.</i>, 2008</a>). After <a href="#ref-25">Grigoryev <i>et al.</i> (2011)</a> identified several miRNAs significantly differentially expressed in T-lymphocytes, they showed a decrease in mRNA expression for target genes of upregulated miRNA molecules. This was confirmed by inhibiting two of these miRNA targets (miR-221 and miR-155) in CD4<sup>+</sup> cells, which increased lymphocyte proliferation by liberating four (PIK3R1, FOS, IRS2, and IKBKE) gene targets, hence favouring their proliferation and survival. MiR-155 overexpression has been shown to increase <i>in vivo</i> antiviral CD8<sup>+</sup> T cell responses (<a href="#ref-24">Gracias <i>et al.</i>, 2013</a>). Among the highlighted miRNA gene targets above, IKKE (IKBKE) was the only one captured in this study and identified in the top three proteins. MiRNAs and their related disease pathway, hsa05131 (microbial infection, shigellosis) and cellular process, hsa01430 (cell communication), could suggest the possibility of successful viral transmission and disease occurrence through gene regulation within each pathway. Knowledge of other regulatory elements such as transcription factors and drug targets for related genes within the network, suggests a complex regulatory platform for the control of Ebolavirus disease. Transcription factors to gene targets like CD209 known for antigen binding and immune presentation could be further molecularly analysed as potential targets for gene regulation and disease prevention within the host.</p><p class="" id=d24891e1864>Gene products in the HLA region (chromosome 6) facilitate antigenic protein processing and peptides presentation to CD8<sup>+</sup> cytotoxic T lymphocytes (CTLs) and CD4<sup>+</sup> T helper cells (<a href="#ref-13">Coffin, 1996</a>; <a href="#ref-18">Dyer <i>et al.</i>, 1997</a>). HLA alleles multiplicity has favoured great species diversity as individuals differentially adapt to the wide range of microbial agents such as HIV-1. Optimal immune defence against HIV-1 could depend on the combined intervention of CD4<sup>+</sup> and CD8<sup>+</sup> lymphocytes (<a href="#ref-59">Rosenberg <i>et al.</i>, 1997</a>) wherein each polymorphic class I and class II loci contributes separately to the resultant immune response. CD209 favors specificity of HIV antigen presentation to MHC-II alleles while dendritic cells promote HIV-specific CD4<sup>+</sup> cells activation and eventual infection. Similarity between HIV-1 and Ebolavirus in the use of antigen-immune interactions to penetrate the host cell could be seen from related genes identified in the network. Components of the immune system with protective role against infection of Ebolavirus are not clearly known due to the fact that the pathogen replicates at unexpected high rates, overwhelming host infected cells and immune defenses with related protein synthesis mechanisms (<a href="#ref-61">Sanchez <i>et al.</i>, 2001</a>).</p><p class="" id=d24891e1904>From our study, HLA class I peptide antigenicity and frequency values for VGP and MXP within the pathogen population, showed no significant statistical difference. Their specificity was tied to HLA*A02:01 and HLA*A02:02 alleles for all the validated peptides, unlike differential selectivity observed for other tested host alleles. This was in conformity with host expression of HLA*A02 allele against the HIV-1 virus expressed in the Botswana (<a href="#ref-53">Novitsky <i>et al.</i>, 2001</a>) and Rwandan population (<a href="#ref-72">Tang <i>et al.</i>, 1999</a>). The FLLQLNETI epitope for VGP was specific to the Zaire Ebolavirus with a single occurrence while the other VGP and all the MXP epitopes were related to other viral species with multiple occurrences. Although the Zaire strain has been considered the most lethal (<a href="#ref-20">Feldmann <i>et al.</i>, 1994</a>; <a href="#ref-63">Sanchez <i>et al.</i>, 1996</a>), the observed transmission intensity (TRI) for the FLLQLNETI epitope was relatively low compared to the FLTNTIRGV epitope for VGP (Bundibugyo and Ta forest), with a TRI twice that of the former. This brings two questions to mind; 1) Is the Ebolavirus epidemic caused mainly by the Zaire Ebola species? and, 2) What causes the sudden change in antigenicity that results in epidemic trends currently observed in West Africa (Liberia, Sierra Leone and Equatorial Guinea). One possible solution could be due to the high phylogenic interspecies differences observed within the VGP genomic structure, suggesting a species specific (pairwise identity) pathogenic driven occurrence. The grouping of Zaire Ebolavirus species with other related species and not vice versa could suggest a derivation of other species from the Zaire virus, hence the host immunity may have adapted to keeping the Zaire strain below epidemic levels. Introduction of high antigenic variants from related strains could be the driving force of the epidemic levels observed.</p><p class="" id=d24891e1931>HLA class II antigenic against frequency values for identified epitopes, presented with high statistical differences for VGP and MXP genomic structures. The validated peptides showed high antigenic values for HLA II thus favouring a high TRI. The most common host allelic frequencies for VGP and MXP were HLA-DRB1*01:01 and HLA-DRB1*01:04 and were consistent with that of the Botswana population carrying the HIV-1 virus though different for other alleles observed with high frequencies in that population. The viral species identified for selected HLA-II peptide epitopes were predominantly and specifically Zaire Ebolavirus. All epitopes presented with low TRIs except for QKMYSFDSTTAAIML which had a TRI &gt; 10 for the MXP genomic structure. This was contrary to the HLA-I high TRI data observed for VGP genomic structure of the Zaire Ebolavirus. Given that specificity of antigen presentation to HLA-II immune proteins is facilitated by CD209, MXP should contribute highly to immune response and signal transmissions downstream. MXP has not always been associated with antigenic interactions but the fact that it could interact with VGP at the viral surface makes its contribution to immune response of considerable importance.</p><p class="" id=d24891e1935>Antigenicity of peptide epitopes for HLA-DQA-B were statistically significant for VGP and not MXP. The VGP validated epitopes were dominant for Zaire Ebolavirus species while those of MXP were dominant for Reston Ebolavirus. Both genomic structures showed high frequencies for HLA-DQA1_05_04-DQB1_05_03 while only frequencies for MXP epitopes were high for HLA-DQA1_03_01-DQB1_03_01. Only HLA-DQA1-B1*03 was in conformity with the alleles identified for the Botswana HIV-1 infected individuals. This allele was specific to MXP and dominantly Reston Ebolavirus, suggesting a possible contribution to immune activation. The study from Botswana genotyped humans for HLA-II allele frequencies and from our study suggests immune specificity to different Ebola genome structures. This observation highlights the difference in antigenicity between the Ebolavirus and HIV-1 virus. Though the low TRI and lack of significant difference for MXP epitopes, the observed antigenic specificity with that of VGP genomic structure could play vital roles for viral pathogenesis within the host.</p><p class="" id=d24891e1938>The multiple occurrences of several antigenic epitopes for a given viral species could suggest repeat sequences in tandem within the genome known as retrotransposons, which favor high genome variation and transmission. Previous work done by several authors on the similarity of reverse transcriptase (<i>pol</i> gene) in retroelements including retrotransposons and retroviruses such as Ebolavirus, suggest that retroviruses could have evolved from long terminal repeat (LRT) retrotransposons by acquiring a functional <i>env</i> gene (<a href="#ref-49">McClure, 1991</a>; <a href="#ref-80">Xiong &amp; Eickbush, 1990</a>). Therefore, the <i>env</i> gene (VGP) should be critical for viral transmission in its host and could be targeted with anti-retroviral technology currently used in HIV patients. Its identification in the interactome suggests an interaction with several human proteins involved in signal transduction. The interplay between the MXP, VGP and their related interacting human proteins makes all these various genes potential targets for Ebolavirus control through drug/vaccine design or the use of genetic technology through interference of viral replication.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d24891e1959>Conclusion</h2><p class="" id=d24891e1962>This study is the first of its kind that has exploited all possible viral antigenic targets and possible systemic routes in the host that could be targeted individually or together for the control of Ebolavirus disease. From this study, the phylogenetic relationship distinguished in the viral envelope of Ebolaviruses and their similarity to HIV-1 viral genomic structures shows that common pathways to pathogenic manifestations within the host are eminent. The ability to clearly understand cellular pathways driving pathogenicity is critical for arresting rapid and abundant cytokine activation leading to shock and organ malfunction. Though the Zaire Ebolavirus has been identified as the most virulent; the TRI for this species generally shows a low transmission rate compared to others, which is in accordance with viral-host cohabitation and adaptation. This suggests that, epidemic occurrences of the Ebolavirus disease could result from related species which have no genetic adaptation with its host. The sequence repeats predicted within antigenic epitopes, occurred more for the non-Zaire Ebola viral species. The identified antigenic epitope targets for this species could be used for drug/vaccine designs. Potential microRNAs, transcription factors and known drugs identified for most gene targets, suggest possible points in the viral pathogenic pathway that could be the focus of modern genetic technology for arresting viral replication and epidemics.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d24891e1968>Methods</h2><div class=section><a name=d24891e1971 class=n-a></a><h3 class=section-title>Phylogenetic analysis of retrieved Ebola and related human protein sequences</h3><p class="" id=d24891e1976>The Geneious software (V.6.1.8) (<a href="#ref-40">Kearse <i>et al.</i>, 2012</a>) and its routine plugin packages were used for extracting and analyzing obtained sequences for various Ebolavirus species. The key word Ebolavirus, was used to search the UniProtKB (<a href="#ref-46">Magrane &amp; Consortium, 2011</a>) (<a href="#TS1">Table S1</a>), resulting in 348 protein sequence variants (database searched in September, 2014), from the five main regional strains highly associated with Ebola Hemorrhagic Fever (<a href="#ref-17">Dowell <i>et al.</i>, 1999</a>), which are: Zaire Ebolavirus, Sudan Ebolavirus, Bundibugyo Ebolavirus (from Uganda), Ta Ebolavirus (from Cot dIvoire) and Reston Ebolavirus (from the Philippines). The sequences also included related mammalian protein sequences (<i>Homo sapiens</i>, <i>Mus musculus</i>, <i>Rattus norvergicus</i>) associated with the viral genome based on genetic motifs, domains and Gene Ontology (GO) terms (<a href="#ref-1">Ashburner <i>et al.</i>, 2000</a>) captured in various phyla. Sequences were aligned using a novel method for rapid multiple sequence alignment based on fast Fourier transform (MAFFT V7.017) (<a href="#ref-39">Katoh <i>et al.</i>, 2002</a>). The parameters involved an auto alignment algorithm, a Blosum 62 (<a href="#ref-50">Mihalek <i>et al.</i>, 2007</a>) scoring matrix, a gap penalty of 1.5 and an offset value = 0.123. The aligned sequences were then subjected to a Geneious tree builder which uses pairwise genetic distances from the sequence alignment, for tree construction, while basing on the following parameters: <a href="#ref-36">Jukes &amp; Cantor (1969)</a> genetic distance model for amino acid substitution, Unweighted Pair Group Method with Arithmetic mean (UPGMA) (<a href="#ref-84">Yu-Shiang <i>et al.</i>, 2014</a>), for tree building and jacknifing (<a href="#ref-35">Jones, 1974</a>) while sampling for the best tree (random seed = 932, 120; replicates = 500; support threshold = 80%). Sequence clusters identified from the tree were exported in FASTA format for MHC HLA class I and II epitope predictions. UniProt accession numbers were extracted and used for protein interaction predictions.</p></div><div class=section><a name=d24891e2039 class=n-a></a><h3 class=section-title>Protein interaction predictions</h3><p class="" id=d24891e2044>UniProt accession numbers for the 348 sequences were loaded into Cytoscape software (V.2.8.1) (<a href="#ref-65">Shannon <i>et al.</i>, 2003</a>), a bioinformatics platform for molecular interaction networks visualization with integration of identified interactions to other biological data, and its routine plugins were used to predict and analyze the network. APID2NET (<a href="#ref-28">Hernandez-Toro <i>et al.</i>, 2007</a>), was used to predict the protein interaction map. This tool queries interactome data from the Agile Protein Interaction Data Analyzer (APID) server (<a target=xrefwindow href="http://bioinfow.dep.usal.es/apid/" id=d24891e2058>http://bioinfow.dep.usal.es/apid/</a>) providing an interactive analysis of individual protein-protein interaction information into a network. During the interaction, the program considers parameters like GO terms, InterPro domains (<a href="#ref-32">Hunter <i>et al.</i>, 2012</a>), PFAM domains (<a href="#ref-6">Bateman <i>et al.</i>, 2002</a>), experimental data for validated interactions and all necessary genetic information captured in the APID database for each protein. Network Analyzer, a Cytoscape plugin was used to evaluate node attributes for the complex network and it considers parameters such as: degree distribution (<a href="#ref-3">Barabsi &amp; Oltvai, 2004</a>; <a href="#ref-16">Diestel, 2005</a>), neighborhood connectivity (<a href="#ref-47">Maslov &amp; Sneppen, 2002</a>), shortest paths (<a href="#ref-78">Watts &amp; Strogatz, 1998</a>), clustering coefficients (<a href="#ref-3">Barabsi &amp; Oltvai, 2004</a>), shared neighbors, topological coefficients (<a href="#ref-69">Stelzl <i>et al.</i>, 2005</a>), stress centrality (<a href="#ref-66">Shimbel, 1953</a>), betweenness centrality (<a href="#ref-11">Brandes, 2001</a>) and closeness centrality (<a href="#ref-51">Newman, 2003</a>) to name a few. The Biological Network Genes Ontology tool (BiNGO) was used to determine full GO terms significantly overrepresented in our gene set (<a href="#ref-45">Maere <i>et al.</i>, 2005</a>) with species target <i>Homo sapiens</i>. The plugin CyTargetLinker (<a href="#ref-42">Kutmon <i>et al.</i>, 2013</a>) was used to extend the interaction network with regulatory elements such as: miRNA-target (<a href="#ref-31">Hsu <i>et al.</i>, 2014</a>), drug-target or TF-target interactions and TargetScan (<a href="#ref-21">Friedman <i>et al.</i>, 2009</a>) to identify genes regulated by these elements. Identified microRNA molecules were associated to particular pathways based on the Kyoto Encyclopedia of Genes and Genomes (KEGG) (<a href="#ref-37">Kanehisa <i>et al.</i>, 2014</a>).</p></div><div class=section><a name=d24891e2141 class=n-a></a><h3 class=section-title>Epitope predictions, antigenic evaluation and MHC HLA class I &amp; II distribution</h3><p class="" id=d24891e2146>The various Ebolavirus sequence sub clusters, [virion envelope glycoprotein, VGP (N = 63) and Matrix protein, MXP (N = 19)] were separately submitted for: 1) MHC class I epitope predictions at the HLA restrictor 1.2 Server (<a href="#ref-19">Erup Larsen <i>et al.</i>, 2011</a>), a tool for patient-specific predictions of HLA restriction elements and optimal epitopes (8  11 amino acids) within peptides and 2) MHC class II epitope predictions at Net MHCIIpan 3.0 server (<a href="#ref-38">Karosiene <i>et al.</i>, 2013</a>) which predicts binding of peptides (9  19 amino acids long) to MHCII alleles for three human isotypes (HLA-DR, HLA-DP and HLA-DQ). Given the vacuum of information on the MHC HLA class I &amp; II allele types in Ebola stricken populations, selected alleles associated with the HIV virus in African related populations (<a href="#ref-72">Tang <i>et al.</i>, 1999</a>; <a href="#ref-53">Novitsky <i>et al.</i>, 2001</a>) were considered for use in this study since both viral species have been shown to possess the homologous hairpin structural envelope glycoprotein (gp160) (<a href="#ref-77">Watanabe <i>et al.</i>, 2000</a>), which is a target for several HIV vaccines. Based on previous work done by our group (<a href="#ref-54">Ojwang <i>et al.</i>, 2014</a>), nine monomers predictions were better preferred for MHC class I, HLA-A alleles while 15 monomers were better preferred for MHC class II, HLA-DRB and HLA-DQ alleles (<a href="#T3">Table 3</a>).</p><div class="table-wrap panel clearfix"><a name=T3 class=n-a></a><div class=caption><h3>Table 3. MHC class I and II allele variants used to predict Ebola antigenic peptide epitopes.</h3><p id=d24891e2199>Nine monomers and fifteen monomers were predicted for HLA-I and II alleles respectively.</p></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d24891e2203 class=n-a></a><thead><a name=d24891e2205 class=n-a></a><tr><a name=d24891e2207 class=n-a></a><th align=left colspan=1 rowspan=1><a name=d24891e2209 class=n-a></a>MHC class I</th><th align=left colspan=1 rowspan=1><a name=d24891e2212 class=n-a></a>MHC class II</th><th colspan=1 rowspan=1><a name=d24891e2215 class=n-a></a></th></tr><tr><a name=d24891e2218 class=n-a></a><th align=left colspan=1 rowspan=1><a name=d24891e2220 class=n-a></a><i>HLA-A alleles</i></th><th align=left colspan=1 rowspan=1><a name=d24891e2224 class=n-a></a><i>HLA-DRB allele</i></th><th align=left colspan=1 rowspan=1><a name=d24891e2228 class=n-a></a><i>HLA-DQ alleles</i></th></tr></thead><tbody><a name=d24891e2234 class=n-a></a><tr><a name=d24891e2236 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e2238 class=n-a></a>HLA-A01:01</td><td colspan=1 rowspan=1><a name=d24891e2241 class=n-a></a>DRB-01:01</td><td colspan=1 rowspan=1><a name=d24891e2244 class=n-a></a>DQA1-01:01:DQB1-02:01</td></tr><tr><a name=d24891e2248 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e2250 class=n-a></a>HLA-A01:02</td><td colspan=1 rowspan=1><a name=d24891e2253 class=n-a></a>DRB-01:04</td><td colspan=1 rowspan=1><a name=d24891e2256 class=n-a></a>DQA1-01:04:DQB1-02:04</td></tr><tr><a name=d24891e2260 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e2262 class=n-a></a>HLA-A02:01</td><td colspan=1 rowspan=1><a name=d24891e2265 class=n-a></a>DRB-02:01</td><td colspan=1 rowspan=1><a name=d24891e2268 class=n-a></a>DQA1-03:01:DQB1-03:01</td></tr><tr><a name=d24891e2272 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e2274 class=n-a></a>HLA-A02:02</td><td colspan=1 rowspan=1><a name=d24891e2277 class=n-a></a>DRB-02:04</td><td colspan=1 rowspan=1><a name=d24891e2280 class=n-a></a>DQA1-03:03:DQB1-03:04</td></tr><tr><a name=d24891e2284 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e2286 class=n-a></a>HLA-A02:04</td><td colspan=1 rowspan=1><a name=d24891e2289 class=n-a></a>DRB-03:01</td><td colspan=1 rowspan=1><a name=d24891e2292 class=n-a></a>DQA1-04:01:DQB1:04:01</td></tr><tr><a name=d24891e2297 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e2299 class=n-a></a></td><td colspan=1 rowspan=1><a name=d24891e2301 class=n-a></a>DRB-03:04</td><td colspan=1 rowspan=1><a name=d24891e2304 class=n-a></a>DQA1-04:04:DQB1-04:04</td></tr><tr><a name=d24891e2308 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e2310 class=n-a></a></td><td colspan=1 rowspan=1><a name=d24891e2312 class=n-a></a>DRB-04:01</td><td colspan=1 rowspan=1><a name=d24891e2315 class=n-a></a>DQA1-05:01:DQB1-05:01</td></tr><tr><a name=d24891e2319 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e2321 class=n-a></a></td><td colspan=1 rowspan=1><a name=d24891e2323 class=n-a></a>DRB-04:04</td><td colspan=1 rowspan=1><a name=d24891e2326 class=n-a></a>DQA1-05:04:DQB1-05:03</td></tr><tr><a name=d24891e2330 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e2332 class=n-a></a></td><td colspan=1 rowspan=1><a name=d24891e2334 class=n-a></a>DRB-05:01</td><td colspan=1 rowspan=1><a name=d24891e2337 class=n-a></a>DQA1-06:02:DQB1-06:04</td></tr><tr><a name=d24891e2341 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e2343 class=n-a></a></td><td colspan=1 rowspan=1><a name=d24891e2345 class=n-a></a>DRB-05:04</td><td colspan=1 rowspan=1><a name=d24891e2348 class=n-a></a></td></tr><tr><a name=d24891e2351 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e2353 class=n-a></a></td><td colspan=1 rowspan=1><a name=d24891e2355 class=n-a></a>DRB-06:01</td><td colspan=1 rowspan=1><a name=d24891e2358 class=n-a></a></td></tr><tr><a name=d24891e2362 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e2364 class=n-a></a></td><td colspan=1 rowspan=1><a name=d24891e2366 class=n-a></a>DRB-06:04</td><td colspan=1 rowspan=1><a name=d24891e2369 class=n-a></a></td></tr><tr><a name=d24891e2372 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e2374 class=n-a></a></td><td colspan=1 rowspan=1><a name=d24891e2376 class=n-a></a>DRB-07:01</td><td colspan=1 rowspan=1><a name=d24891e2379 class=n-a></a></td></tr><tr><a name=d24891e2382 class=n-a></a><td colspan=1 rowspan=1><a name=d24891e2384 class=n-a></a></td><td colspan=1 rowspan=1><a name=d24891e2386 class=n-a></a>DRB:07:04</td><td colspan=1 rowspan=1><a name=d24891e2389 class=n-a></a></td></tr></tbody></table></div><p class="" id=d24891e2395>Peptides were selected on two criteria; threshold affinity for strong binders (0.5 for percentage rank and 50 for IC50) and threshold affinity for weak binders (1 for percentage rank and 100 for IC50). Only strong binders were considered for further analysis. Files containing strong binder epitopes for each Ebola structural genomic class variant and for each species was generated in FASTA format and submitted to Vaxijen software (V.2.0) (<a target=xrefwindow href="http://www.ddg-pharmfac.net/vaxijen/VaxiJen/VaxiJen.html" id=d24891e2397>http://www.ddg-pharmfac.net/vaxijen/VaxiJen/VaxiJen.html</a>). Viral antigenic prediction filter was used at a cutoff of 0.5 and all epitopes with antigenicity values (peptide score)  0.5 separately for MHC class I and II alleles were further considered for analysis.</p></div><div class=section><a name=d24891e2402 class=n-a></a><h3 class=section-title>Calculating Transmission Intensity (TRI) for selected epitopes</h3><p class="" id=d24891e2407>For every validated epitope in our data, the peptide scores and peptide frequencies were considered for the calculation of a novel value called TRANSMISSION INTENSITY (TRI) which translates how high or low the disease transmission will develop into an epidemic situation within the population. The value was based on the ratio of peptide score (PS)/peptide frequency (PF). If TRI was around one, it means the transmission is stable and could easily be contained to elimination. If TRI &gt; 1, it means, the transmission poses a bigger risk to the infected individuals given that high antigenicity will activate a high kinetic and signalling response pathway (<a href="#ref-82">Yamashita <i>et al.</i>, 1998</a>) reaching epidemic levels due to the host immune system generating high antibody levels against the virus possibly leading to hypotensive shock, characterized by; fever, myalgia, malaise, severe bleeding and coagulation abnormalities, including gastrointestinal bleeding, rash, and a range of hematological irregularities, such as lymphopenia and neutrophilia (<a href="#ref-14">Colebunders &amp; Borchert, 2000</a>). If TRI &lt; 1, it means, the transmission poses a low risk within the population and could easily be eliminated by the host immune system. Given that antigenicity is low and peptide frequency is high, the host quickly develops immunity against the pathogen. The different transmission intensities will depend on the MHC HLA allele type and its frequency within the population.</p></div><div class=section><a name=d24891e2421 class=n-a></a><h3 class=section-title>Statistical analysis</h3><p class="" id=d24891e2426>Batch analysis for evaluating node attributes for the network was used to fit the best line between the data points using the least squares method (Weisstein, <a target=xrefwindow href="http://mathworld.wolfram.com/" id=d24891e2428>www.mathworld.wolfram.com</a>). GO terms for the predicted interactome were validated based on the Hypergeometric test after Benjamini &amp; Hochberg False Discovery Rate (FDR) (<a href="#ref-8">Benjamini &amp; Hochberg, 1995</a>) correction and at a significance level of 0.05. Files for each structural genomic class variant per species was used to evaluate frequency distribution for epitopes against peptide scores, HLA allele frequency and frequency within each species protein sequence (supporting <a href="#TS2">Table S2</a>, <a href="#TS3">Table S3</a> and <a href="#TS4">Table S4</a>). After normalizing every value to the largest in each dataset (epitope peptide antigenic score and epitope peptide frequency) of different Ebola sequences, paired student one tailed t-test was performed to compare means between the groups ( = 0.05). This was to evaluate how epitope targets were distributed across different Ebola species and their epidemiological implications.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d24891e2449>Data availability</h2><p class="" id=d24891e2452>The complete list of UniProt KB protein sequence codes for extracted Ebolavirus sequences used for analysis can be found in <a href="#TS1">Table S1</a>.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d24891e1 class=n-a></a><h2 class=main-title id=d25167>Author contributions</h2><p class=metadata-entry><a name=d24891e102 class=n-a></a><p id=d24891e104> All authors contributed to the ideas that led to the development of the manuscript. A.D.O and D.A.A initiated the research idea, D.A.A did the primary research, analysed the data and wrote the manuscript. A.D.O did the proof reading and edited the manuscript for submission.</p></p></div><div class=back-section><a name=d24891e1 class=n-a></a><h2 class=main-title id=d25171>Competing interests</h2><p class=metadata-entry><a name=d24891e108 class=n-a></a><p id=d24891e110> No competing interests were disclosed.</p></p></div><div class=back-section><a name=d24891e1 class=n-a></a><h2 class=main-title id=d25173>Grant information</h2><p>The author(s) declared that no grants were involved in supporting this work.</p></div><div class=back-section><a name=d24891e2462 class=n-a></a><h2 class=main-title id=d24891e2464>Supplementary Tables</h2><div class=section><a name=d24891e2467 class=n-a></a><h3 class=section-title>Table S1.</h3><p class="" id=d24891e2472>UniProt KB protein sequence codes for extracted Ebolavirus sequences used for analysis</p><p class="" id=d24891e2475><a target=xrefwindow href="https://f1000researchdata.s3.amazonaws.com/supplementary/6515/12d2d431-ed33-482a-8669-23d2c4b10c3a.xlsx" id=d24891e2476>Click here to access the data</a>.</p></div><div class=section><a name=d24891e2481 class=n-a></a><h3 class=section-title>Table S2.</h3><p class="" id=d24891e2486>Predicted antigenic epitopes evaluated for frequency distribution against MHC class I immune alleles and different Ebola species</p><p class="" id=d24891e2489><a target=xrefwindow href="https://f1000researchdata.s3.amazonaws.com/supplementary/6515/7c3c483c-931a-4d5e-b20c-0d62746ffb68.xlsx" id=d24891e2490>Click here to access the data</a>.</p></div><div class=section><a name=d24891e2495 class=n-a></a><h3 class=section-title>Table S3.</h3><p class="" id=d24891e2500>Predicted antigenic epitopes evaluated for frequency distribution against MHC class II HLA-DRB1 immune alleles and different Ebola species</p><p class="" id=d24891e2503><a target=xrefwindow href="https://f1000researchdata.s3.amazonaws.com/supplementary/6515/db7b9377-12fc-43d6-b6d9-8ce9a66cb92d.xlsx" id=d24891e2504>Click here to access the data</a>.</p></div><div class=section><a name=d24891e2509 class=n-a></a><h3 class=section-title>Table S4.</h3><p class="" id=d24891e2514>Predicted antigenic epitopes evaluated for frequency distribution against MHC class II HLA-DQA-B immune alleles and different Ebola species</p><p class="" id=d24891e2517><a target=xrefwindow href="https://f1000researchdata.s3.amazonaws.com/supplementary/6515/a257d188-c9f9-4cf6-bb9a-71458ba47a38.xlsx" id=d24891e2518>Click here to access the data</a>.</p></div></div><div class=back-section><a name=d24891e2524 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading is-hidden"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d25462>References</h2><div class="section ref-list"><a name=d24891e2524 class=n-a></a><ul><li><a name=ref-1 class=n-a></a>&nbsp;<span class=citation><a name=d24891e2528 class=n-a></a>Ashburner M, Ball CA, Blake JA, <i> et al.</i>: Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. <i>Nat Genet.</i> 2000; <b>25</b>(1): 2529. <a target=xrefwindow id=d24891e2539 href="http://www.ncbi.nlm.nih.gov/pubmed/10802651">PubMed Abstract </a> | <a target=xrefwindow id=d24891e2542 href="http://dx.doi.org/10.1038/75556">Publisher Full Text </a> | <a target=xrefwindow id=d24891e2546 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3037419">Free Full Text </a></span></li><li><a name=ref-2 class=n-a></a>&nbsp;<span class=citation><a name=d24891e2552 class=n-a></a>Baek D, Villn J, Shin C, <i> et al.</i>: The impact of microRNAs on protein output. <i>Nature.</i> 2008; <b>455</b>(7209): 6471. <a target=xrefwindow id=d24891e2563 href="http://www.ncbi.nlm.nih.gov/pubmed/18668037">PubMed Abstract </a> | <a target=xrefwindow id=d24891e2566 href="http://dx.doi.org/10.1038/nature07242">Publisher Full Text </a> | <a target=xrefwindow id=d24891e2570 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2745094">Free Full Text </a></span></li><li><a name=ref-3 class=n-a></a>&nbsp;<span class=citation><a name=d24891e2576 class=n-a></a>Barabsi AL, Oltvai ZN: Network biology: understanding the cells functional organization. <i>Nat Rev Genet.</i> 2004; <b>5</b>(2): 101113. <a target=xrefwindow id=d24891e2584 href="http://www.ncbi.nlm.nih.gov/pubmed/14735121">PubMed Abstract </a> | <a target=xrefwindow id=d24891e2587 href="http://dx.doi.org/10.1038/nrg1272">Publisher Full Text </a></span></li><li><a name=ref-4 class=n-a></a>&nbsp;<span class=citation><a name=d24891e2593 class=n-a></a>Baskerville A, Bowen ET, Platt GS, <i> et al.</i>: The pathology of experimental Ebola virus infection in monkeys. <i>J Pathol.</i> 1978; <b>125</b>(3): 131138. <a target=xrefwindow id=d24891e2604 href="http://www.ncbi.nlm.nih.gov/pubmed/102747">PubMed Abstract </a> | <a target=xrefwindow id=d24891e2607 href="http://dx.doi.org/10.1002/path.1711250303">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a>&nbsp;<span class=citation><a name=d24891e2613 class=n-a></a>Baskerville A, Fisher-Hoch SP, Neild GH, <i> et al.</i>: Ultrastructural pathology of experimental Ebola haemorrhagic fever virus infection. <i>J Pathol.</i> 1985; <b>147</b>(3): 199209. <a target=xrefwindow id=d24891e2624 href="http://www.ncbi.nlm.nih.gov/pubmed/4067737">PubMed Abstract </a> | <a target=xrefwindow id=d24891e2627 href="http://dx.doi.org/10.1002/path.1711470308">Publisher Full Text </a></span></li><li><a name=ref-6 class=n-a></a>&nbsp;<span class=citation><a name=d24891e2634 class=n-a></a>Bateman A, Birney E, Cerruti L, <i> et al.</i>: The Pfam protein families database. <i>Nucleic Acids Res.</i> 2002; <b>30</b>(1): 276280. <a target=xrefwindow id=d24891e2645 href="http://www.ncbi.nlm.nih.gov/pubmed/11752314">PubMed Abstract </a> | <a target=xrefwindow id=d24891e2648 href="http://dx.doi.org/10.1093/nar/30.1.276">Publisher Full Text </a> | <a target=xrefwindow id=d24891e2652 href="http://www.ncbi.nlm.nih.gov/pmc/articles/99071">Free Full Text </a></span></li><li><a name=ref-7 class=n-a></a>&nbsp;<span class=citation><a name=d24891e2658 class=n-a></a>Bnit L, Dessen P, Heidmann T: Identification, phylogeny, and evolution of retroviral elements based on their envelope genes. <i>J Virol.</i> 2001; <b>75</b>(23): 1170911719. <a target=xrefwindow id=d24891e2666 href="http://www.ncbi.nlm.nih.gov/pubmed/11689652">PubMed Abstract </a> | <a target=xrefwindow id=d24891e2669 href="http://dx.doi.org/10.1128/JVI.75.23.11709-11719.2001">Publisher Full Text </a> | <a target=xrefwindow id=d24891e2672 href="http://www.ncbi.nlm.nih.gov/pmc/articles/114757">Free Full Text </a></span></li><li><a name=ref-8 class=n-a></a>&nbsp;<span class=citation><a name=d24891e2678 class=n-a></a>Benjamini Y, Hochberg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. <i>J R Statist Soc.</i> 1995; <b>57</b>(1): 289300. <a target=xrefwindow id=d24891e2686 href="http://www.stat.purdue.edu/~doerge/BIOINFORM.D/FALL06/Benjamini%20and%20Y%20FDR.pdf">Reference Source</a></span></li><li><a name=ref-9 class=n-a></a>&nbsp;<span class=citation><a name=d24891e2692 class=n-a></a>Bornholdt ZA, Noda T, Abelson DM, <i> et al.</i>: Structural rearrangement of ebola virus VP40 begets multiple functions in the virus life cycle. <i>Cell.</i> 2013; <b>154</b>(4): 763774. <a target=xrefwindow id=d24891e2703 href="http://www.ncbi.nlm.nih.gov/pubmed/23953110">PubMed Abstract </a> | <a target=xrefwindow id=d24891e2706 href="http://dx.doi.org/10.1016/j.cell.2013.07.015">Publisher Full Text </a> | <a target=xrefwindow id=d24891e2710 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4138722">Free Full Text </a></span></li><li><a name=ref-10 class=n-a></a>&nbsp;<span class=citation><a name=d24891e2716 class=n-a></a>Bowen ET, Lloyd G, Harris WJ, <i> et al.</i>: Viral haemorrhagic fever in southern Sudan and northern Zaire. Preliminary studies on the aetiological agent. <i>Lancet.</i> 1977; <b>309</b>(8011): 571573. <a target=xrefwindow id=d24891e2727 href="http://www.ncbi.nlm.nih.gov/pubmed/65662">PubMed Abstract </a> | <a target=xrefwindow id=d24891e2730 href="http://dx.doi.org/10.1016/S0140-6736(77)92001-3">Publisher Full Text </a></span></li><li><a name=ref-11 class=n-a></a>&nbsp;<span class=citation><a name=d24891e2736 class=n-a></a>Brandes U: A faster algorithm for betweenness centrality. <i>J Math Sociol.</i> 2001; <b>25</b>(2): 163177. <a target=xrefwindow id=d24891e2744 href="http://dx.doi.org/10.1080/0022250X.2001.9990249">Publisher Full Text </a></span></li><li><a name=ref-12 class=n-a></a>&nbsp;<span class=citation><a name=d24891e2751 class=n-a></a>Burke JP: Infection control - a problem for patient safety. <i>N Engl J Med.</i> 2003; <b>348</b>(7): 6516. <a target=xrefwindow id=d24891e2759 href="http://www.ncbi.nlm.nih.gov/pubmed/12584377">PubMed Abstract </a> | <a target=xrefwindow id=d24891e2762 href="http://dx.doi.org/10.1056/NEJMhpr020557">Publisher Full Text </a></span></li><li><a name=ref-13 class=n-a></a>&nbsp;<span class=citation><a name=d24891e2768 class=n-a></a>Coffin JM: HIV viral dynamics. <i>AIDS.</i> 1996; <b>10</b>(Suppl 3): S75S84. <a target=xrefwindow id=d24891e2776 href="http://www.ncbi.nlm.nih.gov/pubmed/8970715">PubMed Abstract </a></span></li><li><a name=ref-14 class=n-a></a>&nbsp;<span class=citation><a name=d24891e2782 class=n-a></a>Colebunders R, Borchert M: Ebola haemorrhagic fever--a review. <i>J Infect.</i> 2000; <b>40</b>(1): 1620. <a target=xrefwindow id=d24891e2790 href="http://www.ncbi.nlm.nih.gov/pubmed/10762106">PubMed Abstract </a> | <a target=xrefwindow id=d24891e2793 href="http://dx.doi.org/10.1053/jinf.1999.0603">Publisher Full Text </a></span></li><li><a name=ref-15 class=n-a></a>&nbsp;<span class=citation><a name=d24891e2799 class=n-a></a>Connolly BM, Steele KE, Davis KJ, <i> et al.</i>: Pathogenesis of experimental Ebola virus infection in guinea pigs. <i>J Infect Dis.</i> 1999; <b>179</b>(Suppl 1): S203S217. <a target=xrefwindow id=d24891e2810 href="http://www.ncbi.nlm.nih.gov/pubmed/9988186">PubMed Abstract </a> | <a target=xrefwindow id=d24891e2813 href="http://dx.doi.org/10.1086/514305">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a>&nbsp;<span class=citation><a name=d24891e2819 class=n-a></a>Diestel R: Graph theory. Springer-Verlag, Heidelberg, ISBN 3-540-26182-6. 2005. <a target=xrefwindow id=d24891e2821 href="http://www.freetechbooks.com/graph-theory-3rd-edition-t265.html">Reference Source</a></span></li><li><a name=ref-17 class=n-a></a>&nbsp;<span class=citation><a name=d24891e2827 class=n-a></a>Dowell SF, Mukunu R, Ksiazek TG, <i> et al.</i>: Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidmies  Kikwit. <i>J Infect Dis.</i> 1999; <b>179</b>(Suppl 1): S87S91. <a target=xrefwindow id=d24891e2838 href="http://www.ncbi.nlm.nih.gov/pubmed/9988169">PubMed Abstract </a> | <a target=xrefwindow id=d24891e2841 href="http://dx.doi.org/10.1086/514284">Publisher Full Text </a></span></li><li><a name=ref-18 class=n-a></a>&nbsp;<span class=citation><a name=d24891e2848 class=n-a></a>Dyer WB, Geczy AF, Kent SJ, <i> et al.</i>: Lymphoproliferative immune function in the Sydney Blood Bank Cohort, infected with natural nef/long terminal repeat mutants, and in other long-term survivors of transfusion-acquired HIV-1 infection. <i>AIDS.</i> 1997; <b>11</b>(13): 156574. <a target=xrefwindow id=d24891e2859 href="http://www.ncbi.nlm.nih.gov/pubmed/9365760">PubMed Abstract </a> | <a target=xrefwindow id=d24891e2862 href="http://dx.doi.org/10.1097/00002030-199713000-00004">Publisher Full Text </a></span></li><li><a name=ref-19 class=n-a></a>&nbsp;<span class=citation><a name=d24891e2868 class=n-a></a>Erup Larsen M, Kloverpris H, Stryhn A, <i> et al.</i>: <i>HLArestrictor</i>--a tool for patient-specific predictions of HLA restriction elements and optimal epitopes within peptides. <i>Immunogenetics.</i> 2011; <b>63</b>(1): 4355. <a target=xrefwindow id=d24891e2882 href="http://www.ncbi.nlm.nih.gov/pubmed/21079948">PubMed Abstract </a> | <a target=xrefwindow id=d24891e2886 href="http://dx.doi.org/10.1007/s00251-010-0493-5">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a>&nbsp;<span class=citation><a name=d24891e2892 class=n-a></a>Feldmann H, Nichol ST, Klenk HD, <i> et al.</i>: Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein. <i>Virology.</i> 1994; <b>199</b>(2): 469473. <a target=xrefwindow id=d24891e2903 href="http://www.ncbi.nlm.nih.gov/pubmed/8122375">PubMed Abstract </a> | <a target=xrefwindow id=d24891e2906 href="http://dx.doi.org/10.1006/viro.1994.1147">Publisher Full Text </a></span></li><li><a name=ref-21 class=n-a></a>&nbsp;<span class=citation><a name=d24891e2912 class=n-a></a>Friedman RC, Farh KK, Burge CB, <i> et al.</i>: Most mammalian mRNAs are conserved targets of microRNAs. <i>Genome Res.</i> 2009; <b>19</b>(1): 92105. <a target=xrefwindow id=d24891e2923 href="http://www.ncbi.nlm.nih.gov/pubmed/18955434">PubMed Abstract </a> | <a target=xrefwindow id=d24891e2926 href="http://dx.doi.org/10.1101/gr.082701.108">Publisher Full Text </a> | <a target=xrefwindow id=d24891e2930 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2612969">Free Full Text </a></span></li><li><a name=ref-22 class=n-a></a>&nbsp;<span class=citation><a name=d24891e2936 class=n-a></a>Geisbert TW, Jahrling PB: Differentiation of filoviruses by electron microscopy. <i>Virus Res.</i> 1995; <b>39</b>(23): 129150. <a target=xrefwindow id=d24891e2944 href="http://www.ncbi.nlm.nih.gov/pubmed/8837880">PubMed Abstract </a> | <a target=xrefwindow id=d24891e2947 href="http://dx.doi.org/10.1016/0168-1702(95)00080-1">Publisher Full Text </a></span></li><li><a name=ref-23 class=n-a></a>&nbsp;<span class=citation><a name=d24891e2953 class=n-a></a>Gomis-Rth FX, Dessen A, Timmins J, <i> et al.</i>: The matrix protein VP40 from Ebola virus octamerizes into pore-like structures with specific RNA binding properties. <i>Structure.</i> 2003; <b>11</b>(4): 423433. <a target=xrefwindow id=d24891e2964 href="http://www.ncbi.nlm.nih.gov/pubmed/12679020">PubMed Abstract </a> | <a target=xrefwindow id=d24891e2967 href="http://dx.doi.org/10.1016/S0969-2126(03)00050-9">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a>&nbsp;<span class=citation><a name=d24891e2974 class=n-a></a>Gracias DT, Stelekati E, Hope JL, <i> et al.</i>: The microRNA miR-155 controls CD8<sup>+</sup> T cell responses by regulating interferon signaling. <i>Nat Immunol.</i> 2013; <b>14</b>(6): 593602. <a target=xrefwindow id=d24891e2988 href="http://www.ncbi.nlm.nih.gov/pubmed/23603793">PubMed Abstract </a> | <a target=xrefwindow id=d24891e2992 href="http://dx.doi.org/10.1038/ni.2576">Publisher Full Text </a> | <a target=xrefwindow id=d24891e2995 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3664306">Free Full Text </a></span></li><li><a name=ref-25 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3001 class=n-a></a>Grigoryev YA, Kurian SM, Hart T, <i> et al.</i>: MicroRNA regulation of molecular networks mapped by global microRNA, mRNA, and protein expression in activated T lymphocytes. <i>J Immunol.</i> 2011; <b>187</b>(5): 22332243. <a target=xrefwindow id=d24891e3012 href="http://www.ncbi.nlm.nih.gov/pubmed/21788445">PubMed Abstract </a> | <a target=xrefwindow id=d24891e3015 href="http://dx.doi.org/10.4049/jimmunol.1101233">Publisher Full Text </a> | <a target=xrefwindow id=d24891e3019 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3159804">Free Full Text </a></span></li><li><a name=ref-26 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3025 class=n-a></a>Grimson A, Farh KK, Johnston WK, <i> et al.</i>: MicroRNA targeting specificity in mammals: determinants beyond seed pairing. <i>Mol Cell.</i> 2007; <b>27</b>(1): 91105. <a target=xrefwindow id=d24891e3036 href="http://www.ncbi.nlm.nih.gov/pubmed/17612493">PubMed Abstract </a> | <a target=xrefwindow id=d24891e3039 href="http://dx.doi.org/10.1016/j.molcel.2007.06.017">Publisher Full Text </a> | <a target=xrefwindow id=d24891e3043 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3800283">Free Full Text </a></span></li><li><a name=ref-27 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3049 class=n-a></a>Harty RN, Brown ME, Wang G, <i> et al.</i>: A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding. <i>Proc Natl Acad Sci U S A.</i> 2000; <b>97</b>(25): 1387113876. <a target=xrefwindow id=d24891e3060 href="http://www.ncbi.nlm.nih.gov/pubmed/11095724">PubMed Abstract </a> | <a target=xrefwindow id=d24891e3063 href="http://dx.doi.org/10.1073/pnas.250277297">Publisher Full Text </a> | <a target=xrefwindow id=d24891e3067 href="http://www.ncbi.nlm.nih.gov/pmc/articles/17668">Free Full Text </a></span></li><li><a name=ref-28 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3073 class=n-a></a>Hernandez-Toro J, Prieto C, Las Rivas DJ: APID2NET: unified interactome graphic analyzer. <i>Bioinformatics.</i> 2007; <b>23</b>(18): 24952497. <a target=xrefwindow id=d24891e3081 href="http://www.ncbi.nlm.nih.gov/pubmed/17644818">PubMed Abstract </a> | <a target=xrefwindow id=d24891e3084 href="http://dx.doi.org/10.1093/bioinformatics/btm373">Publisher Full Text </a></span></li><li><a name=ref-29 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3090 class=n-a></a>Hoenen T, Biedenkopf N, Zielecki F, <i> et al.</i>: Oligomerization of Ebola virus VP40 is essential for particle morphogenesis and regulation of viral transcription. <i>J Virol.</i> 2010; <b>84</b>(14): 70537063. <a target=xrefwindow id=d24891e3101 href="http://www.ncbi.nlm.nih.gov/pubmed/20463076">PubMed Abstract </a> | <a target=xrefwindow id=d24891e3104 href="http://dx.doi.org/10.1128/JVI.00737-10">Publisher Full Text </a> | <a target=xrefwindow id=d24891e3108 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2898221">Free Full Text </a></span></li><li><a name=ref-30 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3115 class=n-a></a>Hoenen T, Volchkov V, Kolesnikova L, <i> et al.</i>: VP40 octamers are essential for Ebola virus replication. <i>J Virol.</i> 2005; <b>79</b>(3): 1898905. <a target=xrefwindow id=d24891e3126 href="http://www.ncbi.nlm.nih.gov/pubmed/15650213">PubMed Abstract </a> | <a target=xrefwindow id=d24891e3129 href="http://www.ncbi.nlm.nih.gov/pmc/articles/544139">Free Full Text </a></span></li><li><a name=ref-31 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3135 class=n-a></a>Hsu SD, Tseng YT, Shrestha S, <i> et al.</i>: miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions. <i>Nucl Acids Res.</i> 2014; <b>42</b>(Database issue): D78D85. <a target=xrefwindow id=d24891e3146 href="http://www.ncbi.nlm.nih.gov/pubmed/24304892">PubMed Abstract </a> | <a target=xrefwindow id=d24891e3149 href="http://dx.doi.org/10.1093/nar/gkt1266">Publisher Full Text </a> | <a target=xrefwindow id=d24891e3153 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3965058">Free Full Text </a></span></li><li><a name=ref-32 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3159 class=n-a></a>Hunter S, Jones P, Mitchell A, <i> et al.</i>: InterPro in 2011: new developments in the family and domain prediction database. <i>Nucleic Acids Res.</i> 2012; <b>40</b>(Database issue): D306D312. <a target=xrefwindow id=d24891e3170 href="http://www.ncbi.nlm.nih.gov/pubmed/22096229">PubMed Abstract </a> | <a target=xrefwindow id=d24891e3173 href="http://dx.doi.org/10.1093/nar/gkr948">Publisher Full Text </a> | <a target=xrefwindow id=d24891e3177 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3245097">Free Full Text </a></span></li><li><a name=ref-33 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3183 class=n-a></a>Johnson KM, Lange JV, Webb PA, <i> et al.</i>: Isolation and partial characterisation of a new virus causing acute haemorrhagic fever in Zaire. <i>Lancet.</i> 1977; <b>309</b>(8011): 569571. <a target=xrefwindow id=d24891e3194 href="http://www.ncbi.nlm.nih.gov/pubmed/65661">PubMed Abstract </a> | <a target=xrefwindow id=d24891e3197 href="http://dx.doi.org/10.1016/S0140-6736(77)92000-1">Publisher Full Text </a></span></li><li><a name=ref-34 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3203 class=n-a></a>Johnson RF, Bell P, Harty RN: Effect of Ebola virus proteins GP, NP and VP35 on VP40 VLP morphology. <i>Virol J.</i> 2006; <b>3</b>: 31. <a target=xrefwindow id=d24891e3211 href="http://www.ncbi.nlm.nih.gov/pubmed/16719918">PubMed Abstract </a> | <a target=xrefwindow id=d24891e3214 href="http://dx.doi.org/10.1186/1743-422X-3-31">Publisher Full Text </a> | <a target=xrefwindow id=d24891e3217 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1502131">Free Full Text </a></span></li><li><a name=ref-35 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3223 class=n-a></a>Jones HL: Jackknife estimation of functions of stratum means. <i>Biometrika.</i> 1974; <b>61</b>(2): 343348. <a target=xrefwindow id=d24891e3231 href="http://dx.doi.org/10.1093/biomet/61.2.343">Publisher Full Text </a></span></li><li><a name=ref-36 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3238 class=n-a></a>Jukes TH, Cantor CR: Evolution of Protein Molecules. New York: Academic Press. 1969: 21132. <a target=xrefwindow id=d24891e3240 href="http://garfield.library.upenn.edu/classics1990/A1990CZ67100002.pdf">Reference Source</a></span></li><li><a name=ref-37 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3246 class=n-a></a>Kanehisa M, Goto S, Sato Y, <i> et al.</i>: Data, information, knowledge and principle: back to metabolism in KEGG. <i>Nucleic Acids Res.</i> 2014; <b>42</b>(Database issue): D199D205. <a target=xrefwindow id=d24891e3257 href="http://www.ncbi.nlm.nih.gov/pubmed/24214961">PubMed Abstract </a> | <a target=xrefwindow id=d24891e3260 href="http://dx.doi.org/10.1093/nar/gkt1076">Publisher Full Text </a> | <a target=xrefwindow id=d24891e3264 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3965122">Free Full Text </a></span></li><li><a name=ref-38 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3270 class=n-a></a>Karosiene E, Rasmussen M, Blicher T, <i> et al.</i>: <i>NetMHCIIpan</i>-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ. <i>Immunogenetics.</i> 2013; <b>65</b>(10); 711724. <a target=xrefwindow id=d24891e3284 href="http://www.ncbi.nlm.nih.gov/pubmed/23900783">PubMed Abstract </a> | <a target=xrefwindow id=d24891e3288 href="http://dx.doi.org/10.1007/s00251-013-0720-y">Publisher Full Text </a> | <a target=xrefwindow id=d24891e3291 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3809066">Free Full Text </a></span></li><li><a name=ref-39 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3297 class=n-a></a>Katoh K, Misawa K, Kuma K, <i> et al.</i>: MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform. <i>Nucleic Acids Res.</i> 2002; <b>30</b>(14): 30593066. <a target=xrefwindow id=d24891e3308 href="http://www.ncbi.nlm.nih.gov/pubmed/12136088">PubMed Abstract </a> | <a target=xrefwindow id=d24891e3311 href="http://dx.doi.org/10.1093/nar/gkf436">Publisher Full Text </a> | <a target=xrefwindow id=d24891e3315 href="http://www.ncbi.nlm.nih.gov/pmc/articles/135756">Free Full Text </a></span></li><li><a name=ref-40 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3321 class=n-a></a>Kearse M, Moir R, Wilson A, <i> et al.</i>: Geneious Basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data. <i>Bioinformatics.</i> 2012; <b>28</b>(12): 16471649. <a target=xrefwindow id=d24891e3332 href="http://www.ncbi.nlm.nih.gov/pubmed/22543367">PubMed Abstract </a> | <a target=xrefwindow id=d24891e3335 href="http://dx.doi.org/10.1093/bioinformatics/bts199">Publisher Full Text </a> | <a target=xrefwindow id=d24891e3339 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3371832">Free Full Text </a></span></li><li><a name=ref-41 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3345 class=n-a></a>Kuhn JH: Filoviruses. A compendium of 40 years of epidemiological, clinical, and laboratory studies. <i>Arch Virol Suppl.</i> Springer, Wien. ISBN 978-3-211-69495-4, 2008; <b>20</b>: 13360. <a target=xrefwindow id=d24891e3353 href="http://www.ncbi.nlm.nih.gov/pubmed/18637412">PubMed Abstract </a> | <a target=xrefwindow id=d24891e3356 href="http://dx.doi.org/10.1007/978-3-211-69495-4">Publisher Full Text </a></span></li><li><a name=ref-42 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3363 class=n-a></a>Kutmon M, Kelder T, Mandaviya P, <i> et al.</i>: CyTargetLinker: a cytoscape app to integrate regulatory interactions in network analysis. <i>PLoS One.</i> 2013; <b>8</b>(12): e82160. <a target=xrefwindow id=d24891e3374 href="http://www.ncbi.nlm.nih.gov/pubmed/24340000">PubMed Abstract </a> | <a target=xrefwindow id=d24891e3377 href="http://dx.doi.org/10.1371/journal.pone.0082160">Publisher Full Text </a> | <a target=xrefwindow id=d24891e3381 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3855388">Free Full Text </a></span></li><li><a name=ref-43 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3387 class=n-a></a>Leroy EM, Baize S, Mavoungou E, <i> et al.</i>: Sequence analysis of the GP, NP, VP40 and VP24 genes of Ebola virus isolated from deceased, surviving and asymptomatically infected individuals during the 1996 outbreak in Gabon: comparative studies and phylogenetic characterization. <i>J Gen Virol.</i> 2002; <b>83</b>(Pt 1): 6773. <a target=xrefwindow id=d24891e3398 href="http://www.ncbi.nlm.nih.gov/pubmed/11752702">PubMed Abstract </a></span></li><li><a name=ref-44 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3404 class=n-a></a>Mackenzie I, Lever A: Management of sepsis. <i>BMJ.</i> 2007; <b>335</b>(7626): 929932. <a target=xrefwindow id=d24891e3412 href="http://www.ncbi.nlm.nih.gov/pubmed/17974689">PubMed Abstract </a> | <a target=xrefwindow id=d24891e3415 href="http://dx.doi.org/10.1136/bmj.39346.696620.AE">Publisher Full Text </a> | <a target=xrefwindow id=d24891e3418 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2048841">Free Full Text </a></span></li><li><a name=ref-45 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3424 class=n-a></a>Maere S, Heymans K, Kuiper M: <i>BiNGO</i>: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. <i>Bioinformatics.</i> 2005; <b>21</b>(16): 34483449. <a target=xrefwindow id=d24891e3435 href="http://www.ncbi.nlm.nih.gov/pubmed/15972284">PubMed Abstract </a> | <a target=xrefwindow id=d24891e3438 href="http://dx.doi.org/10.1093/bioinformatics/bti551">Publisher Full Text </a></span></li><li><a name=ref-46 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3444 class=n-a></a>Magrane M, Consortium U: UniProt Knowledgebase: a hub of integrated protein data. <i>Database (Oxford).</i> 2011; <b>2011</b>: bar009. <a target=xrefwindow id=d24891e3452 href="http://www.ncbi.nlm.nih.gov/pubmed/21447597">PubMed Abstract </a> | <a target=xrefwindow id=d24891e3455 href="http://dx.doi.org/10.1093/database/bar009">Publisher Full Text </a> | <a target=xrefwindow id=d24891e3458 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3070428">Free Full Text </a></span></li><li><a name=ref-47 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3464 class=n-a></a>Maslov S, Sneppen K: Specificity and stability in topology of protein networks. <i>Science.</i> 2002; <b>296</b>(5569): 910913. <a target=xrefwindow id=d24891e3472 href="http://www.ncbi.nlm.nih.gov/pubmed/11988575">PubMed Abstract </a> | <a target=xrefwindow id=d24891e3475 href="http://dx.doi.org/10.1126/science.1065103">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3482 class=n-a></a>Mayo MA, Pringle CR: Virus taxonomy--1997. <i>J Gen Virol.</i> 1998; <b>79</b>(Pt 4): 649657. <a target=xrefwindow id=d24891e3490 href="http://www.ncbi.nlm.nih.gov/pubmed/9568957">PubMed Abstract </a></span></li><li><a name=ref-49 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3496 class=n-a></a>McClure MA: Evolution of retroposons by acquisition or deletion of retrovirus-like genes. <i>Mol Biol Evol.</i> 1991; <b>8</b>(6): 835856. <a target=xrefwindow id=d24891e3504 href="http://www.ncbi.nlm.nih.gov/pubmed/1663570">PubMed Abstract </a></span></li><li><a name=ref-50 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3510 class=n-a></a>Mihalek I, Res I, Lichtarge O: Background frequencies for residue variability estimates: BLOSUM revisited. <i>BMC Bioinformatics.</i> 2007; <b>8</b>: 488. <a target=xrefwindow id=d24891e3518 href="http://www.ncbi.nlm.nih.gov/pubmed/18162129">PubMed Abstract </a> | <a target=xrefwindow id=d24891e3521 href="http://dx.doi.org/10.1186/1471-2105-8-488">Publisher Full Text </a> | <a target=xrefwindow id=d24891e3524 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2267808">Free Full Text </a></span></li><li><a name=ref-51 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3530 class=n-a></a>Newman MEJ: A measure of betweenness centrality based on random walks. arXiv cond-mat/0309045. 2003. <a target=xrefwindow id=d24891e3532 href="http://arxiv.org/pdf/cond-mat/0309045.pdf">Reference Source</a></span></li><li><a name=ref-52 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3538 class=n-a></a>Noda T, Sagara H, Suzuki E, <i> et al.</i>: Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP. <i>J Virol.</i> 2002; <b>76</b>(10): 48554865. <a target=xrefwindow id=d24891e3549 href="http://www.ncbi.nlm.nih.gov/pubmed/11967302">PubMed Abstract </a> | <a target=xrefwindow id=d24891e3552 href="http://dx.doi.org/10.1128/JVI.76.10.4855-4865.2002">Publisher Full Text </a> | <a target=xrefwindow id=d24891e3556 href="http://www.ncbi.nlm.nih.gov/pmc/articles/136157">Free Full Text </a></span></li><li><a name=ref-53 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3562 class=n-a></a>Novitsky V, Rybak N, McLane MF, <i> et al.</i>: Identification of human immunodeficiency virus type 1 subtype C Gag-, Tat-, Rev-, and Nef-specific elispot-based cytotoxic T-lymphocyte responses for AIDS vaccine design. <i>J Virol.</i> 2001; <b>75</b>(19): 92109228. <a target=xrefwindow id=d24891e3573 href="http://www.ncbi.nlm.nih.gov/pubmed/11533184">PubMed Abstract </a> | <a target=xrefwindow id=d24891e3576 href="http://dx.doi.org/10.1128/JVI.75.19.9210-9228.2001">Publisher Full Text </a> | <a target=xrefwindow id=d24891e3580 href="http://www.ncbi.nlm.nih.gov/pmc/articles/114489">Free Full Text </a></span></li><li><a name=ref-54 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3587 class=n-a></a>Ojwang AME, Daniel AA, Anton D, <i> et al.</i>: <i>In silico</i> identification of universal HLA stimulating B and T-cell restricted mage epitopes for vaccine development. <i>OJB. Online Journal of Bioinformatics.</i> 2014; <b>15</b>(1): 114132. <a target=xrefwindow id=d24891e3601 href="http://onljvetres.com/mageepitopeabs2014.htm">Reference Source</a></span></li><li><a name=ref-55 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3607 class=n-a></a>Palacios EH, Weiss A: Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation. <i>Oncogene.</i> 2004; <b>23</b>(48): 79908000. <a target=xrefwindow id=d24891e3615 href="http://www.ncbi.nlm.nih.gov/pubmed/15489916">PubMed Abstract </a> | <a target=xrefwindow id=d24891e3618 href="http://dx.doi.org/10.1038/sj.onc.1208074">Publisher Full Text </a></span></li><li><a name=ref-56 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3624 class=n-a></a>Panchal RG, Ruthel G, Kenny TA, <i> et al.</i>: <i>In vivo</i> oligomerization and raft localization of Ebola virus protein VP40 during vesicular budding. <i>Proc Natl Acad Sci U S A.</i> 2003; <b>100</b>(26): 1593615941. <a target=xrefwindow id=d24891e3638 href="http://www.ncbi.nlm.nih.gov/pubmed/14673115">PubMed Abstract </a> | <a target=xrefwindow id=d24891e3642 href="http://dx.doi.org/10.1073/pnas.2533915100">Publisher Full Text </a> | <a target=xrefwindow id=d24891e3645 href="http://www.ncbi.nlm.nih.gov/pmc/articles/307671">Free Full Text </a></span></li><li><a name=ref-57 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3651 class=n-a></a>Parren PW, Geisbert TW, Maruyama T, <i> et al.</i>: Pre- and postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody. <i>J Virol.</i> 2002; <b>76</b>(12): 64086412. <a target=xrefwindow id=d24891e3662 href="http://www.ncbi.nlm.nih.gov/pubmed/12021376">PubMed Abstract </a> | <a target=xrefwindow id=d24891e3665 href="http://dx.doi.org/10.1128/JVI.76.12.6408-6412.2002">Publisher Full Text </a> | <a target=xrefwindow id=d24891e3669 href="http://www.ncbi.nlm.nih.gov/pmc/articles/136210">Free Full Text </a></span></li><li><a name=ref-58 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3675 class=n-a></a>Ploegh HL: Viral strategies of immune evasion. <i>Science.</i> 1998; <b>280</b>(5361): 248253. <a target=xrefwindow id=d24891e3683 href="http://www.ncbi.nlm.nih.gov/pubmed/9535648">PubMed Abstract </a> | <a target=xrefwindow id=d24891e3686 href="http://dx.doi.org/10.1126/science.280.5361.248">Publisher Full Text </a></span></li><li><a name=ref-59 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3692 class=n-a></a>Rosenberg ES, Billingsley JM, Caliendo AM, <i> et al.</i>: Vigorous HIV-1-specific CD4<sup>+</sup> T cell responses associated with control of viremia. <i>Science.</i> 1997; <b>278</b>(5342): 14471450. <a target=xrefwindow id=d24891e3706 href="http://www.ncbi.nlm.nih.gov/pubmed/9367954">PubMed Abstract </a> | <a target=xrefwindow id=d24891e3710 href="http://dx.doi.org/10.1126/science.278.5342.1447">Publisher Full Text </a></span></li><li><a name=ref-60 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3717 class=n-a></a>Rudd CE, Trevillyan JM, Dasgupta JD, <i> et al.</i>: The CD4 receptor is complexed in detergent lysates to a protein-tyrosine kinase (pp58) from human T lymphocytes. <i>Proc Natl Acad Sci USA.</i> 1988; <b>85</b>(14): 51905194. <a target=xrefwindow id=d24891e3728 href="http://www.ncbi.nlm.nih.gov/pubmed/2455897">PubMed Abstract </a> | <a target=xrefwindow id=d24891e3731 href="http://dx.doi.org/10.1073/pnas.85.14.5190">Publisher Full Text </a> | <a target=xrefwindow id=d24891e3735 href="http://www.ncbi.nlm.nih.gov/pmc/articles/281714">Free Full Text </a></span></li><li><a name=ref-61 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3741 class=n-a></a>Sanchez A, Khan AS, Zaki SR, <i> et al.</i>: Filoviridae: Marburg and Ebola viruses. In Knipe DM and Howley PM (ed.), <i>Fields virology</i>. Lippincott, Williams and Wilkins, Philadelphia, Pa. 2001: 12791304. </span></li><li><a name=ref-62 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3753 class=n-a></a>Sanchez A, Kiley MP, Holloway BP, <i> et al.</i>: Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus. <i>Virus Res.</i> 1993; <b>29</b>(3): 215240. <a target=xrefwindow id=d24891e3764 href="http://www.ncbi.nlm.nih.gov/pubmed/8237108">PubMed Abstract </a> | <a target=xrefwindow id=d24891e3767 href="http://dx.doi.org/10.1016/0168-1702(93)90063-S">Publisher Full Text </a></span></li><li><a name=ref-63 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3773 class=n-a></a>Sanchez A, Trappier SG, Mahy BWJ, <i> et al.</i>: The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. <i>Proc Natl Acad. Sci.</i> 1996; <b>93</b>(8): 36023607. <a target=xrefwindow id=d24891e3784 href="http://www.ncbi.nlm.nih.gov/pubmed/8622982">PubMed Abstract </a> | <a target=xrefwindow id=d24891e3787 href="http://dx.doi.org/10.1073/pnas.93.8.3602">Publisher Full Text </a> | <a target=xrefwindow id=d24891e3791 href="http://www.ncbi.nlm.nih.gov/pmc/articles/39657">Free Full Text </a></span></li><li><a name=ref-64 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3797 class=n-a></a>Selbach M, Schwanhusser B, Thierfelder N, <i> et al.</i>: Widespread changes in protein synthesis induced by microRNAs. <i>Nature.</i> 2008; <b>455</b>(7209): 5863. <a target=xrefwindow id=d24891e3808 href="http://www.ncbi.nlm.nih.gov/pubmed/18668040">PubMed Abstract </a> | <a target=xrefwindow id=d24891e3811 href="http://dx.doi.org/10.1038/nature07228">Publisher Full Text </a></span></li><li><a name=ref-65 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3817 class=n-a></a>Shannon P, Markiel A, Ozier O, <i> et al.</i>: Cytoscape: a software environment for integrated models of biomolecular interaction networks. <i>Genome Res.</i> 2003; <b>13</b>(11): 2498504. <a target=xrefwindow id=d24891e3828 href="http://www.ncbi.nlm.nih.gov/pubmed/14597658">PubMed Abstract </a> | <a target=xrefwindow id=d24891e3831 href="http://dx.doi.org/10.1101/gr.1239303">Publisher Full Text </a> | <a target=xrefwindow id=d24891e3835 href="http://www.ncbi.nlm.nih.gov/pmc/articles/403769">Free Full Text </a></span></li><li><a name=ref-66 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3842 class=n-a></a>Shimbel A: Structural parameters of communication networks. <i>Bull Math Biophys.</i> 1953; <b>15</b>(4): 501507. <a target=xrefwindow id=d24891e3850 href="http://dx.doi.org/10.1007/BF02476438">Publisher Full Text </a></span></li><li><a name=ref-67 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3856 class=n-a></a>Siegert R, Shu HL, Slenczka W, <i> et al.</i>: Zur tiologie einer unbekannten, von Affen ausgegangenen menschlichen Infektionskrankheit. <i>Dtsch Med Wochenschr.</i> 1967; <b>92</b>(51): 23412343. <a target=xrefwindow id=d24891e3867 href="http://dx.doi.org/10.1055/s-0028-1106144">Publisher Full Text </a></span></li><li><a name=ref-68 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3873 class=n-a></a>Simmons G, Wool-Lewis RJ, Baribaud F, <i> et al.</i>: Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence. <i>J Virol.</i> 2002; <b>76</b>(5): 25182528. <a target=xrefwindow id=d24891e3884 href="http://www.ncbi.nlm.nih.gov/pubmed/11836430">PubMed Abstract </a> | <a target=xrefwindow id=d24891e3887 href="http://dx.doi.org/10.1128/jvi.76.5.2518-2528.2002">Publisher Full Text </a> | <a target=xrefwindow id=d24891e3891 href="http://www.ncbi.nlm.nih.gov/pmc/articles/153797">Free Full Text </a></span></li><li><a name=ref-69 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3897 class=n-a></a>Stelzl U, Worm U, Lalowski M, <i> et al.</i>: A human protein-protein interaction network: a resource for annotating the proteome. <i>Cell.</i> 2005; <b>122</b>(6): 957968. <a target=xrefwindow id=d24891e3908 href="http://www.ncbi.nlm.nih.gov/pubmed/16169070">PubMed Abstract </a> | <a target=xrefwindow id=d24891e3911 href="http://dx.doi.org/10.1016/j.cell.2005.08.029">Publisher Full Text </a></span></li><li><a name=ref-70 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3917 class=n-a></a>Strher U, West E, Bugany H, <i> et al.</i>: Infection and activation of monocytes by Marburg and Ebola viruses. <i>J Virol.</i> 2001; <b>75</b>(22): 1102511033. <a target=xrefwindow id=d24891e3928 href="http://www.ncbi.nlm.nih.gov/pubmed/11602743">PubMed Abstract </a> | <a target=xrefwindow id=d24891e3931 href="http://dx.doi.org/10.1128/JVI.75.22.11025-11033.2001">Publisher Full Text </a> | <a target=xrefwindow id=d24891e3935 href="http://www.ncbi.nlm.nih.gov/pmc/articles/114683">Free Full Text </a></span></li><li><a name=ref-71 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3941 class=n-a></a>Sullivan NJ, Geisbert TW, Geisbert JB, <i> et al.</i>: Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates. <i>Nature.</i> 2003; <b>424</b>(6949): 681684. <a target=xrefwindow id=d24891e3952 href="http://www.ncbi.nlm.nih.gov/pubmed/12904795">PubMed Abstract </a> | <a target=xrefwindow id=d24891e3955 href="http://dx.doi.org/10.1038/nature01876">Publisher Full Text </a></span></li><li><a name=ref-72 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3962 class=n-a></a>Tang J, Costello C, Keet IP, <i> et al.</i>: HLA class I homozygosity accelerates disease progression in human immunodeficiency virus type 1 infection. <i>AIDS Res Hum Retroviruses.</i> 1999; <b>15</b>(4): 317324. <a target=xrefwindow id=d24891e3973 href="http://www.ncbi.nlm.nih.gov/pubmed/10082114">PubMed Abstract </a> | <a target=xrefwindow id=d24891e3976 href="http://dx.doi.org/10.1089/088922299311277">Publisher Full Text </a></span></li><li><a name=ref-73 class=n-a></a>&nbsp;<span class=citation><a name=d24891e3982 class=n-a></a>Towner JS, Khristova ML, Sealy TK, <i> et al.</i>: Marburgvirus genomics and association with a large hemorrhagic fever outbreak in Angola. <i>J Virol.</i> 2006; <b>80</b>(13): 64976516. <a target=xrefwindow id=d24891e3993 href="http://www.ncbi.nlm.nih.gov/pubmed/16775337">PubMed Abstract </a> | <a target=xrefwindow id=d24891e3996 href="http://dx.doi.org/10.1128/JVI.00069-06">Publisher Full Text </a> | <a target=xrefwindow id=d24891e4000 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1488971">Free Full Text </a></span></li><li><a name=ref-74 class=n-a></a>&nbsp;<span class=citation><a name=d24891e4006 class=n-a></a>Towner JS, Sealy TK, Khristova ML, <i> et al.</i>: Newly discovered Ebola virus associated with hemorrhagic fever outbreak in Uganda. <i>PLoS Pathog.</i> 2008; <b>4</b>(11): e1000212. <a target=xrefwindow id=d24891e4017 href="http://www.ncbi.nlm.nih.gov/pubmed/19023410">PubMed Abstract </a> | <a target=xrefwindow id=d24891e4020 href="http://dx.doi.org/10.1371/journal.ppat.1000212">Publisher Full Text </a> | <a target=xrefwindow id=d24891e4024 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2581435">Free Full Text </a></span></li><li><a name=ref-75 class=n-a></a>&nbsp;<span class=citation><a name=d24891e4030 class=n-a></a>Veillette A, Bookman MA, Horak EM, <i> et al.</i>: The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56<sup>lck</sup>. <i>Cell.</i> 1988; <b>55</b>(2): 301308. <a target=xrefwindow id=d24891e4044 href="http://www.ncbi.nlm.nih.gov/pubmed/3262426">PubMed Abstract </a> | <a target=xrefwindow id=d24891e4048 href="http://dx.doi.org/10.1016/0092-8674(88)90053-0">Publisher Full Text </a></span></li><li><a name=ref-76 class=n-a></a>&nbsp;<span class=citation><a name=d24891e4054 class=n-a></a>Volchkov VE, Becker S, Volchkova VA, <i> et al.</i>: GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases. <i>Virology.</i> 1995; <b>214</b>(2): 421430. <a target=xrefwindow id=d24891e4065 href="http://www.ncbi.nlm.nih.gov/pubmed/8553543">PubMed Abstract </a> | <a target=xrefwindow id=d24891e4068 href="http://dx.doi.org/10.1006/viro.1995.0052">Publisher Full Text </a></span></li><li><a name=ref-77 class=n-a></a>&nbsp;<span class=citation><a name=d24891e4074 class=n-a></a>Watanabe N, Yamaguchi T, Akimoto Y, <i> et al.</i>: Induction of M-phase arrest and apoptosis after HIV-1 Vpr expression through uncoupling of nuclear and centrosomal cycle in HeLa cells. <i>Exp Cell Res.</i> 2000; <b>258</b>(2): 261269. <a target=xrefwindow id=d24891e4085 href="http://www.ncbi.nlm.nih.gov/pubmed/10896777">PubMed Abstract </a> | <a target=xrefwindow id=d24891e4088 href="http://dx.doi.org/10.1006/excr.2000.4908">Publisher Full Text </a></span></li><li><a name=ref-78 class=n-a></a>&nbsp;<span class=citation><a name=d24891e4095 class=n-a></a>Watts DJ, Strogatz SH: Collective dynamics of small-world networks. <i>Nature.</i> 1998; <b>393</b>(6684): 440442. <a target=xrefwindow id=d24891e4103 href="http://www.ncbi.nlm.nih.gov/pubmed/9623998">PubMed Abstract </a> | <a target=xrefwindow id=d24891e4106 href="http://dx.doi.org/10.1038/30918">Publisher Full Text </a></span></li><li><a name=ref-79 class=n-a></a>&nbsp;<span class=citation><a name=d24891e4112 class=n-a></a>Wilson JA, Hevey M, Bakken R, <i> et al.</i>: Epitopes involved in antibody-mediated protection from Ebola virus. <i>Science.</i> 2000; <b>287</b>(5458): 16641666. <a target=xrefwindow id=d24891e4123 href="http://www.ncbi.nlm.nih.gov/pubmed/10698744">PubMed Abstract </a> | <a target=xrefwindow id=d24891e4126 href="http://dx.doi.org/10.1126/science.287.5458.1664">Publisher Full Text </a></span></li><li><a name=ref-80 class=n-a></a>&nbsp;<span class=citation><a name=d24891e4132 class=n-a></a>Xiong Y, Eickbush TH: Origin and evolution of retroelements based upon their reverse transcriptase sequences. <i>EMBO J.</i> 1990; <b>9</b>(10): 33533362. <a target=xrefwindow id=d24891e4140 href="http://www.ncbi.nlm.nih.gov/pubmed/1698615">PubMed Abstract </a> | <a target=xrefwindow id=d24891e4143 href="http://www.ncbi.nlm.nih.gov/pmc/articles/552073">Free Full Text </a></span></li><li><a name=ref-81 class=n-a></a>&nbsp;<span class=citation><a name=d24891e4149 class=n-a></a>Xu L, Sanchez A, Yang Z, <i> et al.</i>: Immunization for Ebola virus infection. <i>Nat Med.</i> 1998; <b>4</b>(1): 3742. <a target=xrefwindow id=d24891e4160 href="http://www.ncbi.nlm.nih.gov/pubmed/9427604">PubMed Abstract </a> | <a target=xrefwindow id=d24891e4163 href="http://dx.doi.org/10.1038/nm0198-037">Publisher Full Text </a></span></li><li><a name=ref-82 class=n-a></a>&nbsp;<span class=citation><a name=d24891e4169 class=n-a></a>Yamashita H, Xu J, Erwin RA, <i> et al.</i>: Differential control of the phosphorylation state of proline-juxtaposed serine residues Ser725 of Stat5a and Ser730 of Stat5b in prolactin-sensitive cells. <i>J Biol Chem.</i> 1998; <b>273</b>(46): 3021830224. <a target=xrefwindow id=d24891e4180 href="http://www.ncbi.nlm.nih.gov/pubmed/9804779">PubMed Abstract </a> | <a target=xrefwindow id=d24891e4183 href="http://dx.doi.org/10.1074/jbc.273.46.30218">Publisher Full Text </a></span></li><li><a name=ref-83 class=n-a></a>&nbsp;<span class=citation><a name=d24891e4189 class=n-a></a>Yang Z, Delgado R, Xu L, <i> et al.</i>: Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins. <i>Science.</i> 1998; <b>279</b>(5353): 10341037. <a target=xrefwindow id=d24891e4200 href="http://www.ncbi.nlm.nih.gov/pubmed/9461435">PubMed Abstract </a> | <a target=xrefwindow id=d24891e4203 href="http://dx.doi.org/10.1126/science.279.5353.1034">Publisher Full Text </a></span></li><li><a name=ref-84 class=n-a></a>&nbsp;<span class=citation><a name=d24891e4210 class=n-a></a>Yu-Shiang L, Chun-Yuan L, Che-Lun H, <i> et al.</i>: GPU-UPGMA: high-performance computing for UPGMA algorithm based on graphics processing units. <i>Concurrency Computat Pract Exper.</i> 2014. <a target=xrefwindow id=d24891e4218 href="http://dx.doi.org/10.1002/cpe.3355">Publisher Full Text </a></span></li></ul></div></div></div> </div> <div class=f1r-article-desk> <section class="o-box o-box--medium u-bg--2 u-mt--2"> <h4 class="u-mt--0 u-mb--2 t-h3 u-weight--md">Looking for the Open Peer Review Reports?</h4> <p class="u-mt--0 u-mb--0 t-h4">They can now be found at the top of the panel on the right, linked from the box entitled Open Peer Review. Choose the reviewer report you wish to read and click the 'read' link. You can also read all the peer review reports by <a target=_blank href="https://f1000research.com/articles/4-166/v1/pdf?article_uuid=c3d18c77-b1b0-4471-9048-77a997d4794e">downloading the PDF</a>.</p> </section> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 24 Jun 2015</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/4-166&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/4-166&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> PepVax, Inc.10411 Motor City Drive, Bethesda, MD, 20817, USA<br/> <sup>2</sup> Current affiliation: NCBI/NLM/NIH, Computational Biology Branch, Bethesda, MD, 20894, USA<br/> <p> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/4-166/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 24 Jun 2015, 4:166 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.6515.1">https://doi.org/10.12688/f1000research.6515.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden">  2015 Achinko D and Dormer A. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Data associated with the article are available under the terms of the <a href="http://creativecommons.org/publicdomain/zero/1.0/" target=_blank data-test-id=box-data-licence-link>Creative Commons Zero "No rights reserved" data waiver</a> (CC0 1.0 Public domain dedication). </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=6991 data-id=6515 data-downloads="" data-views="" data-scholar="10.12688/f1000research.6515.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/4-166/v1/pdf?article_uuid=c3d18c77-b1b0-4471-9048-77a997d4794e" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.6515.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Achinko D and Dormer A. Epitope specificity and protein signaling interactions driving epidemic occurrences of Ebola disease [version 1; peer review: peer review discontinued] <i>F1000Research</i> 2015, <b>4</b>:166 (<a href="https://doi.org/10.12688/f1000research.6515.1" target=_blank>https://doi.org/10.12688/f1000research.6515.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=6515 id=mobile-track-article-signin-6515 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/6515?target=/articles/4-166"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=6991 /> <input name=articleId type=hidden value=6515 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status no-border-and-margin "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Peer review discontinued <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> <strong>Peer review at <em>F1000Research</em> is author-driven. Currently no reviewers are being invited.</strong> <a href="/faqs#articles-not-under-peer-review">What does this mean?</a> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 24 Jun 2015</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/4-166&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/4-166&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Peer review discontinued</h3> </div> <div class="o-layout__item u-mb--2"> <div class="u-pl u-pr"> <p class="u-mt--0 u-mb--1 t-h4">Peer review at F1000Research is author-driven. Currently no reviewers are being invited.</p> <p class="u-mt--0 u-mb--1 t-h4"><a href="/faqs#articles-not-under-peer-review">What does this mean?</a></p> </div> </div> <div class=o-layout__item> <div class="p-article__sidebar-highlight u-mb--2"> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="u-ib u-middle"><em>AWAITING PEER REVIEW</em></div> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/4-166&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/4-166/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Epitope specificity and protein signaling...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/4-166/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/4-166/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/4-166/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Achinko D and Dormer A');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/4-166/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/4-166",
            templates : {
                twitter : "Epitope specificity and protein signaling interactions driving.... Achinko D and Dormer A, published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/4-166/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Epitope specificity and protein signaling interactions driving epidemic occurrences of Ebola disease", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Research Article", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Epitope specificity and protein signaling interactions driving epidemic occurrences of Ebola disease", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/6515/6991")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("articles", "article", "6991");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "16902": 0,
                           "16903": 0,
                           "9671": 0,
                           "16904": 0,
                           "9672": 0,
                           "16905": 0,
                           "16906": 0,
                           "9236": 0,
                           "9237": 0,
                           "9238": 0,
                           "9239": 0,
                           "25182": 0,
                           "25183": 0,
                           "25184": 0,
                           "25185": 0,
                           "25186": 0,
                           "17253": 0,
                           "20020": 0,
                           "20021": 0,
                           "20022": 0,
                           "20023": 0,
                           "14522": 0,
                           "14523": 0,
                           "14524": 0,
                           "20220": 2,
                           "14525": 0,
                           "14526": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "c431d234-3903-4e56-812f-3ca99eea98e3";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/4-166.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/4-166.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/4-166.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/4-166.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/4-166.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>